prednisolone has been researched along with Age-Related Osteoporosis in 277 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of vitamin K2 (Vit K2) alone or in combination with etidronate and risedronate on bone loss, osteoclast induction, and inflammation in patients with rheumatoid arthritis (RA)." | 9.13 | Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. ( Morishita, M; Nagashima, M; Takahashi, H; Takenouchi, K; Wauke, K, 2008) |
| " To clarify whether administration of vitamin K, which enhances bone formation, prevents prednisolone-induced loss of bone mineral density (BMD), a randomized, prospective, controlled study was conducted on 20 patients with chronic glomerulonephritis scheduled for treatment with prednisolone." | 9.09 | Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. ( Hishida, A; Kimura, M; Miyaji, T; Yonemura, K, 2000) |
| "The aim of this study was to compare the action of two regimens of intravenous (iv) pamidronate in the primary prevention of glucocorticoid-induced osteoporosis (GC-OP)." | 9.09 | Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J, 2001) |
| " administration of disodium pamidronate can effectively achieve primary prevention of glucocorticoid-induced osteoporosis (GIOP)." | 9.08 | Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J; Stoffel, M, 1997) |
| "A glucocorticoid-induced osteoporosis phenotype as seen in mammals was induced in regenerating scalar bone of zebrafish treated with prednisolone." | 7.80 | Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales. ( de Vrieze, E; Flik, G; Metz, JR; Peters, HM; Spanings, FA; van Kessel, MA, 2014) |
| "The current study aimed to evaluate the potential role of dehydroepiandrosterone (DHEA) in the protection and intervention of glucocorticoid-induced secondary osteoporosis in female rats." | 7.78 | Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats. ( Ahmed, HH; Eskander, EF; Morcos, NY; Seoudi, DM; Shalby, AB, 2012) |
| "The present study assessed the potential role of leptin administration in the protection and intervention against glucocorticoid-induced secondary osteoporosis in female rats." | 7.78 | Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. ( Ahmed, HH; Eskander, EF; Morcos, NY; Seoudi, DM; Shalby, AB, 2012) |
| "Osteoporosis is an adverse effect of prednisolone therapy, although no study has been conducted on myasthenia gravis patients receiving high-dose prednisolone." | 7.72 | Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. ( Araki, Y; Hayashi, N; Konno, S; Nakazato, A; Nemoto, H; Nomoto, N; Sugimoto, H; Wakata, N, 2004) |
| " Both disorders had been controlled for around 15 years by oral prednisolone and a cholinesterase inhibitor following surgical removal of invasive thymoma and radiotherapy, but muscular weakness due to myalgia and an increase in serum levels of myogenic enzymes, mainly ascribable to the recurrence of PM, reappeared immediately after cessation of these drugs, which was done because the patient had multiple bone fractures and severe osteoporosis due to the long-term corticosteroid therapy." | 7.72 | Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis. ( Gono, T; Hoshi, K; Ikeda, S; Matsuda, M; Shimojima, Y; Yamamoto, K; Yoshida, K, 2004) |
| "D-003 (5, 25 and 200 mg/kg) prevented trabecular bone loss and femoral neck osteonecrosis induced with prednisolone in Sprague Dawley rats, also increasing osteoblast surface and reducing bone resorption parameters." | 7.72 | Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats. ( León, F; Más, R; Mendoza, N; Mendoza, S; Noa, M, 2004) |
| "To compare the bone-mass effects of intermittent cyclic etidronate administration in patients of various rheumatic disease patients with corticosteroid-induced osteoporosis." | 7.71 | [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis]. ( Koshiba, M; Kumagai, S; Maekawa, S; Morinobu, A; Morinobu, S; Nakamura, T; Sugimoto, T; Yamauchi, M, 2002) |
| "We investigated the possible ameliorating and preventive effect of swimming on prednisolone-induced osteoporosis in elderly rats." | 7.68 | Effect of swimming on prednisolone-induced osteoporosis in elderly rats. ( Azevedo, J; Azoury, R; Brooks, GA; Greenfield, C; Leichter, I; Oman, S; Statter, M; Swissa-Sivan, A; Viguie, C; Zinker, BA, 1992) |
| "Ipriflavone, 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one, was administered orally for 12 weeks to male rats with prednisolone-induced osteoporosis." | 7.67 | Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. ( Kinoshita, M; Shimizu, Y; Shino, A; Shirakawa, Y; Tsukuda, R; Yamazaki, I, 1986) |
| "Prednisolone, used as a standard initial treatment for immune thrombocytopenia (ITP), is an important risk factor for osteoporosis." | 5.41 | Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective. ( Yamasaki, S, 2023) |
| "Kynurenine analysis was performed by HPLC." | 5.32 | Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. ( Darlington, LG; Forrest, CM; Kennedy, A; Stone, TW; Stoy, N, 2003) |
| " Subjects had just developed systemic autoimmune diseases and were randomized to be treated with 1 mg/kg/day prednisolone and alfacalcidol 1 microg/day alone (alfacalcidol group; n = 22), or prednisolone and alfacalcidol 1 microg/day with alendronate 5 mg/day (alendronate group; n = 25), each for 18 months." | 5.13 | Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy. ( Nakayamada, S; Nawata, M; Okada, Y; Saito, K; Tanaka, Y, 2008) |
| "To investigate the effects of vitamin K2 (Vit K2) alone or in combination with etidronate and risedronate on bone loss, osteoclast induction, and inflammation in patients with rheumatoid arthritis (RA)." | 5.13 | Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results. ( Morishita, M; Nagashima, M; Takahashi, H; Takenouchi, K; Wauke, K, 2008) |
| " To clarify whether administration of vitamin K, which enhances bone formation, prevents prednisolone-induced loss of bone mineral density (BMD), a randomized, prospective, controlled study was conducted on 20 patients with chronic glomerulonephritis scheduled for treatment with prednisolone." | 5.09 | Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. ( Hishida, A; Kimura, M; Miyaji, T; Yonemura, K, 2000) |
| "The aim of this study was to compare the action of two regimens of intravenous (iv) pamidronate in the primary prevention of glucocorticoid-induced osteoporosis (GC-OP)." | 5.09 | Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J, 2001) |
| " administration of disodium pamidronate can effectively achieve primary prevention of glucocorticoid-induced osteoporosis (GIOP)." | 5.08 | Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. ( Boutsen, Y; Devogelaer, JP; Esselinckx, W; Jamart, J; Stoffel, M, 1997) |
| "The results show that intermittent cyclical etidronate therapy with calcium and vitamin D supplementation significantly increases lumbar spine BMD in patients with osteoporosis resulting from long-term treatment with corticosteroids." | 5.08 | A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment. ( Li, F; Moniz, C; Pack, S; Pitt, P; Todd, P; Webber, D, 1998) |
| "A controlled clinical trial was carried out in 40 patients at risk of osteoporosis because of long-term treatment with prednisolone (5 to 20 mg/day) to determine the efficacy and tolerance of microcrystalline hydroxyapatite compound (MCHC) when used to prevent the appearance or progression of osteoporosis: 32 patients were treated with 6 to 8 g MCHC for 12 months and 8 served as an untreated control group." | 5.05 | Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy. ( Lynn, AH; Pines, A; Raafat, H; Whittington, J, 1984) |
| "Treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) with ursodeoxycholic acid (UDCA) has been in common use since 1985." | 4.81 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. ( Holtmeier, J; Leuschner, U, 2001) |
| " Upon histologic examination, the tumor was determined to be parathyroidal chief-cell hyperplasia and the patient was treated with melphalan and prednisolone." | 4.79 | A case of primary hyperparathyroidism accompanying multiple myeloma. ( Hayakawa, N; Kageyama, J; Kashihara, N; Kataoka, H; Kawashima, M; Makino, H; Mimura, Y; Ogura, T; Otsuka, F; Yamauchi, T, 1997) |
| "The purpose of this study was to demonstrate the anti-osteoporosis effects of SC extract and alkaloids in prednisolone (Pre)-induced OP of zebrafish, and then to explore the potential mechanism of SC on system level by network pharmacology." | 3.96 | Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis. ( Chen, Y; Huang, TQ; Jiang, ZM; Liu, EH; Liu, WJ; Wang, ZY; Xiao, PT, 2020) |
| "We conducted a series of nested case-control analyses in GCA patients to examine the effect of increasing dose of prednisolone on the risk of developing diabetes, glaucoma, osteoporosis, fractures, serious infection requiring hospitalization, and death." | 3.85 | Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis. ( Collinson, N; Jick, SS; Klearman, M; Meier, CR; Musselman, D; Napalkov, P; Sarsour, K; Stone, JH; Tuckwell, K; Wilson, JC, 2017) |
| " In addition, they prevent the alteration of bone markers in a prednisolone-induced osteoporosis model in adult zebrafish scales, whereas their esterified forms do not." | 3.83 | Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease. ( Banfi, G; Carnovali, M; Ciuffreda, P; Mariotti, M; Ottria, R; Pasqualetti, S, 2016) |
| "A glucocorticoid-induced osteoporosis phenotype as seen in mammals was induced in regenerating scalar bone of zebrafish treated with prednisolone." | 3.80 | Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales. ( de Vrieze, E; Flik, G; Metz, JR; Peters, HM; Spanings, FA; van Kessel, MA, 2014) |
| " aestivum (200 and 400 mg/kg/day, po, for 30 days) and risedronate (20 microg/kg, sc, five times a week for 30 days) following methyl prednisolone sodium succinate (10 mg/kg, sc, thrice a week for 4 weeks) induced osteoporosis in Wistar rats showed an increase in the serum levels of bone mineral content markers, decrease in the serum and urinary levels of bone resorption markers." | 3.80 | Role of Triticum aestivum aqueous extract in glucocorticoid induced osteoporosis in rats. ( Abbagoni, S; Banji, D; Banji, OJ; Chiluka, VL, 2014) |
| "Prednisolone-induced osteoporosis model using zebrafish was used to screen the antiosteoporotic active parts of Dipsacus Radix, in order to investigate the applicability and rationality of the zebrafish model of osteoporosis." | 3.80 | [Screening on antiosteoporotic active parts of dipsacus radix based on zebrafish model]. ( Jia, XB; Jing, LJ; Wang, CM; Wei, YJ; Xie, L, 2014) |
| " The objective of this study has been to test the effects of procedures or drugs affecting bone metabolism on articular cartilage in rats with prednisolone-induced osteoporosis and to evaluate the outcomes of physical activity with treadmill and vibration platform training on articular cartilage." | 3.79 | The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. ( Carnazza, ML; Castorina, S; Giunta, S; Leonardi, R; Loreto, C; Musumeci, G; Pichler, K; Trovato, FM; Weinberg, AM, 2013) |
| "The current study aimed to evaluate the potential role of dehydroepiandrosterone (DHEA) in the protection and intervention of glucocorticoid-induced secondary osteoporosis in female rats." | 3.78 | Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats. ( Ahmed, HH; Eskander, EF; Morcos, NY; Seoudi, DM; Shalby, AB, 2012) |
| "The present study assessed the potential role of leptin administration in the protection and intervention against glucocorticoid-induced secondary osteoporosis in female rats." | 3.78 | Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats. ( Ahmed, HH; Eskander, EF; Morcos, NY; Seoudi, DM; Shalby, AB, 2012) |
| " Six-month-old male Wistar-Imamichi rats (n = 32) were divided into the following four groups with equal average body weight: (1) 4-week age-matched controls, (2) 4-week GC (prednisolone, 10 mg/kg daily, i." | 3.77 | Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats. ( Hayakawa, N; Kato, S; Marumo, K; Mihara, M; Saito, M; Sakai, S; Shiraishi, A; Ushiku, C, 2011) |
| "Experimental prednisolone administration has been shown to cause osteoporosis in animals." | 3.76 | [Experimental steroid osteoporosis in rats and the way to restore the bone tissue structure]. ( Iakupov, RR; Ibatullina, RB; Kaiumov, FA; Rakhmatullin, FA, 2010) |
| " Non-Afro-Caribbean race and exposure to prednisolone >10 mg daily were significantly associated with reduced BMD, while age and menopause were associated with osteoporosis." | 3.73 | Prevalence and predictors of fragility fractures in systemic lupus erythematosus. ( Amft, N; Bowman, S; Crabtree, N; Gordon, C; Situnayake, D; Skan, J; Yee, CS, 2005) |
| "The aim of this study was to evaluate the effect of calcitriol on bone mass in patients with corticosteroid induced osteoporosis." | 3.72 | Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids. ( Hahn, M; Knoll, P; Köhn, H; Levi, M; Mirzaei, S; Pohl, W; Zajicek, HK, 2003) |
| "12%) patients were receiving prednisolone for >/=3 months, but no osteoporosis prophylaxis other than Ca/D." | 3.72 | Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients. ( Dolan, AL; Goble, CM; Koshy, E; Waker, M, 2004) |
| "Osteoporosis is an adverse effect of prednisolone therapy, although no study has been conducted on myasthenia gravis patients receiving high-dose prednisolone." | 3.72 | Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. ( Araki, Y; Hayashi, N; Konno, S; Nakazato, A; Nemoto, H; Nomoto, N; Sugimoto, H; Wakata, N, 2004) |
| " Both disorders had been controlled for around 15 years by oral prednisolone and a cholinesterase inhibitor following surgical removal of invasive thymoma and radiotherapy, but muscular weakness due to myalgia and an increase in serum levels of myogenic enzymes, mainly ascribable to the recurrence of PM, reappeared immediately after cessation of these drugs, which was done because the patient had multiple bone fractures and severe osteoporosis due to the long-term corticosteroid therapy." | 3.72 | Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis. ( Gono, T; Hoshi, K; Ikeda, S; Matsuda, M; Shimojima, Y; Yamamoto, K; Yoshida, K, 2004) |
| "D-003 (5, 25 and 200 mg/kg) prevented trabecular bone loss and femoral neck osteonecrosis induced with prednisolone in Sprague Dawley rats, also increasing osteoblast surface and reducing bone resorption parameters." | 3.72 | Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats. ( León, F; Más, R; Mendoza, N; Mendoza, S; Noa, M, 2004) |
| "Bone densitometry was performed on 129 adult patients with prednisolone-treated uveitis from four centres." | 3.71 | Corticosteroid-induced osteoporosis in patients with uveitis. ( Anderton, LC; Cheong, FM; Jones, NP; Lesnik-Oberstein, S; Murray, PI; Pavesio, C; Stanford, MR; Whallett, A, 2002) |
| "To compare the bone-mass effects of intermittent cyclic etidronate administration in patients of various rheumatic disease patients with corticosteroid-induced osteoporosis." | 3.71 | [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis]. ( Koshiba, M; Kumagai, S; Maekawa, S; Morinobu, A; Morinobu, S; Nakamura, T; Sugimoto, T; Yamauchi, M, 2002) |
| "Time since transplantation and cumulative prednisolone doses were significantly higher in patients who had osteoporosis of the lumbar vertebrae (P=0." | 3.71 | Osteoporosis after renal transplantation: single center experience. ( Erdal, R; Guvener, N; Haberal, M; Işiklar, I; Turan, M; Ugur, A, 2001) |
| "Despite a far lower cumulative GC dose in comparison with patients treated with systemic corticosteroids continuously, after adjusting for BMI and lung function, osteoporosis of the lumbar spine was most frequent in patients receiving > 1,000 mg of prednisolone cumulatively, administered in multiple courses for the treatment of exacerbations of COPD." | 3.71 | Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens. ( Dekhuijzen, PN; Dubois, EF; Röder, E; Schweitzer, DH; Zwinderman, AE, 2002) |
| "We report a rare case of ulcerative colitis (UC) associated with methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa infections in multiple organs, and with compressive fracture from osteoporosis after the administration of high-dose prednisolone and azathioprine." | 3.70 | Severe complications of ulcerative colitis after high-dose prednisolone and azathioprine treatment. ( Abo, Y; Kawamura, YJ; Masaki, T; Matsuda, K; Muto, T; Uchida, H; Watanabe, T, 1999) |
| "Calcium-D3 Nikomed was used in combined treatment of 20 patients with hormone-dependent bronchial asthma (BA) receiving glucocorticoid tablets in daily dose 5-40 mg (prednisolone calculation), mean dose 20." | 3.70 | [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma]. ( Amosov, VI; Ememl'ianov, AV; Murzin, BA; Shevelev, SE, 1999) |
| "The aim of the study was an analysis of the frequency of oral steroids prescription to patients with bronchial asthma treated in hospital and of vertebral fractures and deformations as the result of GCS-induced osteoporosis in patients with bronchial asthma taking prednisolone tablets for at least 6 months." | 3.70 | [Osteoporotic fracture of the vertebral body in patients with steroid dependent bronchial asthma]. ( Lebedeva, MK; Lesniak, OM; Lezhnina, MB; Piven', AI, 2000) |
| "We investigated the possible ameliorating and preventive effect of swimming on prednisolone-induced osteoporosis in elderly rats." | 3.68 | Effect of swimming on prednisolone-induced osteoporosis in elderly rats. ( Azevedo, J; Azoury, R; Brooks, GA; Greenfield, C; Leichter, I; Oman, S; Statter, M; Swissa-Sivan, A; Viguie, C; Zinker, BA, 1992) |
| "Thirty-one patients with rheumatoid arthritis maintained on prednisolone 5 mg daily for an average period of 9." | 3.67 | Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. ( Hajiroussou, VJ; Webley, M, 1984) |
| "Ipriflavone, 7-isopropoxy-3-phenyl-4H-1-benzopyran-4-one, was administered orally for 12 weeks to male rats with prednisolone-induced osteoporosis." | 3.67 | Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats. ( Kinoshita, M; Shimizu, Y; Shino, A; Shirakawa, Y; Tsukuda, R; Yamazaki, I, 1986) |
| "We performed a post-hoc analysis of a randomised, placebo-controlled, double blind, dose-response intervention study involving 32 healthy males (age: 22 ± 3 years; BMI 22." | 2.87 | The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial. ( Brands, M; de Jongh, RT; den Heijer, M; Heijboer, AC; Serlie, MJ; van Bommel, EJM; van Raalte, DH, 2018) |
| "Prednisolone treatment showed significant lower osteocalcin levels and lower Z-scores for lumbar spine and femoral neck compared to PAI patients on hydrocortisone." | 2.77 | Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. ( Diederich, S; Koetz, KR; Quinkler, M; Ventz, M, 2012) |
| "Alendronate was effective in suppressing bone resorption and subsequent BMD decrease at the lumbar spine in patients with high-dose GC treatment." | 2.75 | Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study. ( Funakawa, I; Funasaka, Y; Kaji, H; Kanda, F; Kuroki, Y; Murakawa, Y; Sugimoto, T, 2010) |
| "Steroid-induced osteoporosis is a serious adverse effect of this drug." | 2.75 | Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome. ( Amemiya, N; Itabashi, M; Karasawa, K; Kawanishi, K; Kojima, C; Moriyama, T; Nitta, K; Ogawa, T; Shimizu, A; Shiohira, S; Sugiura, H; Takei, T; Tsuchiya, K; Tsukada, M; Uchida, K, 2010) |
| " In the future, more selectively acting substances could achieve an uncoupling of desired and adverse effects." | 2.72 | [Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis]. ( Keyßer, G, 2021) |
| "Osteoporosis frequently occurs in Crohn's disease, often because of corticosteroids." | 2.71 | Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease. ( Bianchi Porro, G; Bollani, S; Felsenberg, D; Graffner, H; Haptén-White, L; Israeli, E; Ljunghall, S; Mills, PR; Persson, T; Schoon, EJ; Stockbrügger, RW; Vatn, M, 2005) |
| " Long-term use of alfacalcidol was not associated with any significant adverse effects in this diverse group of patients." | 2.69 | Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. ( Guillevin, L; Kuntz, D; Menkès, CJ; Nielsen, K; Reginster, JY; Verdickt, W; Wouters, M, 1999) |
| "The longterm benefits of rhGH in the treatment of osteoporosis remain unclear." | 2.69 | Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis. ( Ansell, BM; Davies, UM; Preece, M; Reeve, J; Rooney, M; Woo, PM, 2000) |
| " Twelve healthy subjects (4 m, 8 f) were treated for 1 week at each dosage level, the graduated dosages being given in ascending order." | 2.67 | The assessment of the systemic effects of inhaled glucocorticosteroids. The effects of inhaled budesonide vs oral prednisolone on calcium metabolism. ( Andersson, KE; Jennings, BH; Johansson, SA, 1991) |
| " Long-term administration of 1 alpha-OHD and calcium should be avoided in patients undergoing chronic glucocorticoid therapy because of the risk of the development of nephrolithiasis." | 2.66 | [Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis]. ( Yamada, H, 1989) |
| " Meanwhile, adherence to recommendations on standardized methodologies for registration and report of glucocorticoid adverse events is essential for improving our knowledge and competence in the best management of these important medications." | 2.50 | Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years. ( da Silva, JA; Santiago, T, 2014) |
| "Steroid-induced osteoporosis has been reported to show reduced osteoblastic bone formation and accelerated osteoclastic bone resorption." | 2.44 | [Assessment of bone quality. Bone quality of steroid-induced osteoporosis]. ( Amizuka, N; Li, M; Saito, T, 2008) |
| "Osteoporosis is the most frequent adverse effect observed during glucocorticoids therapy." | 2.43 | [Management of glucocorticoid-induced osteoporosis]. ( Soen, S, 2005) |
| "Osteoporosis is the most frequent adverse effect of glucocorticoids." | 2.43 | [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems]. ( Soen, S, 2006) |
| "Steroid-induced osteoporosis is the most common form of osteoporosis in the dermatological diseases, but there have been only few data concerning the treatment based on clinical evidences." | 2.42 | [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate]. ( Okada, N, 2004) |
| "Fractures and stress fractures in patients with RA are probably much more common." | 2.39 | [Osteoporosis in collagen diseases]. ( Aritomi, H; Momohara, S, 1994) |
| "The role of corticosteroids in treating rheumatoid arthritis is controversial, but recourse to the available evidence of efficacy should guide patient management decisions." | 2.39 | Low dose corticosteroids in early rheumatoid arthritis. Can these drugs slow disease progression? ( Kirwan, JR; Lim, KK, 1996) |
| "When prednisolone was given together with 1 alpha OHD2 or 1 alpha OHD3, renal calcifications were further increased." | 2.37 | Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats. ( Sjödén, G, 1985) |
| "Prednisolone acetate was intragastrically administered to mice for two weeks." | 1.62 | Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway. ( Bu, J; Guo, J; Hasegawa, T; Li, C; Li, M; Liu, B; Liu, H; Si, H; Yang, P, 2021) |
| "BACKGROUND Osteoporosis is a common disorder leading to bone loss." | 1.51 | Fangchinoline Promotes Autophagy and Inhibits Apoptosis in Osteoporotic Rats. ( Dai, X; Ding, W; Shang, X; Zhu, D; Zhu, W, 2019) |
| "Prednisolone (PSL, 5 mg) was subcutaneously inserted in 6-month-old male C57BL/6J mice, and 200 μl of saline, OUB-diluted saline, or nitrogen ultra-fine bubbles (NUB)-diluted saline was intraperitoneally injected three times per week for 8 weeks the day after operations." | 1.46 | Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation. ( Ebina, K; Hirao, M; Iwahashi, T; Kitaguchi, K; Koizumi, K; Matsuoka, H; Morimoto, T; Noguchi, T; Yoshikawa, H, 2017) |
| "Osteoporosis was defined as a bone densitometry T score of less than -2." | 1.43 | Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease. ( Gunson, BK; Hodson, J; Krishnamoorthy, TL; Miezynska-Kurtycz, J; Milkiewicz, P; Neuberger, J; Oo, YH, 2016) |
| "Osteoporosis is one of the most prevalent skeletal system diseases." | 1.43 | IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse. ( Li, X; Yang, HL; Zhang, YY; Zhou, ZY, 2016) |
| "In 4 dogs, prednisolone was administered PO at a dosage of 2 mg/kg once daily for 2 weeks, 1 mg/kg once daily for 4 weeks, and 0." | 1.42 | Quantitative computed tomographic assessment of bone mineral density changes associated with administration of prednisolone or prednisolone and alendronate sodium in dogs. ( Cho, KO; Choi, J; Oh, J; Park, S; Son, KY, 2015) |
| "Our results revealed that COPD was significantly associated with a high risk of osteoporosis, regardless of whether the patients with COPD were corticosteroid users and irrespective of age and sex." | 1.42 | Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. ( Chang, KH; Chen, SJ; Huang, KH; Kao, CH; Kung, PT; Liao, WC; Lin, CL; Tsai, WC, 2015) |
| "The methods used in treatment of osteoporosis induced by glucocorticosteroids are not effective enough." | 1.38 | Effects of thalidomide on the development of bone damage caused by prednisolone in rats. ( Kaczmarczyk-Sedlak, I; Rotko, K; Sedlak, L; Zych, M, 2012) |
| "Patients with chronic obstructive pulmonary disease have a high risk of osteoporosis and fractures." | 1.38 | [Diagnosing and treating osteoporosis in patients with chronic obstructive pulmonary disease]. ( Abrahamsen, B; Brask-Lindemann, D; Eiken, PA; Langdahl, BL; Vestbo, J, 2012) |
| "Systemic mastocytosis is a rare cause of vertebral fractures in young men." | 1.35 | Multimodal therapy for vertebral involvement of systemic mastocytosis. ( Brendel, C; Hamann, C; Hofbauer, LC; Krüger, A; Neubauer, A; Ramaswamy, A; Schnabel, M, 2009) |
| " No relationship was observed between osteoporosis and age, sex, body mass index, duration of hemodialysis therapy, cumulative dosage of any drugs, or use of pulsed methylprednisolone therapy." | 1.35 | Osteoporosis and related risk factors in renal transplant recipients. ( Ahmadpoor, P; Ghafari, A; Makhdoomi, K; Rahimi, E; Reisi, S; Sepehrvand, N, 2009) |
| "Osteopenia was common in both groups (44." | 1.32 | Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone. ( Drexel, H; Gouya, G; Hergan, K; Höfle, G; Holzmüller, H; Hubmann, M; Langer, P, 2003) |
| "Kynurenine analysis was performed by HPLC." | 1.32 | Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. ( Darlington, LG; Forrest, CM; Kennedy, A; Stone, TW; Stoy, N, 2003) |
| "Hypogonadism has been established as a cause of osteoporosis in males, and in this case would explain the occurrence of fractures in the absence of other major risk factors." | 1.31 | Osteoporosis with underlying connective tissue disease: an unusual case. ( De Silva, M; Prasad, R, 2002) |
| "In Crohn's disease, osteoporosis is frequently found." | 1.31 | Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? ( Corstens, FH; de Jong, DJ; Mannaerts, L; Naber, AH; van Rossum, LG, 2002) |
| " They were all affected by inflammatory disorders (rheumatoid arthritis and other connective tissue diseases) and had been in chronic glucocorticoid therapy for at least 8 months, at an average daily dosage of not less than 7." | 1.31 | [The usefulness of the quantitative ultrasound to diagnose glucocorticoids induced osteoporosis]. ( Coaccioli, S; Di Cato, L; Ponteggia, F; Ponteggia, M; Puxeddu, A, 2002) |
| " There was no significant difference between the two genotypes in age, gender, body mass index (BMI), disease duration, disease types, time of glucocorticoid administration and cumulative dosage (P > 0." | 1.31 | Relationship between glucocorticoid-induced osteoporosis and vitamin D receptor genotypes. ( Chen, L; Li, Y; Shen, L; Xu, L; Yu, L, 2002) |
| "In our case, senile osteoporosis was present before the onset of the fracture was recognized on radiographs, and RA and corticosteroid therapy might have further aggravated the porosis, resulting in the destruction of the fossa acetabuli." | 1.31 | A case report of insufficiency fracture of the Fossa acetabuli in a patient with rheumatoid arthritis. ( Nakayama, Y; Ozaki, D; Shirai, Y; Uesaka, S, 2000) |
| "Osteoporosis is not a specific complication of PBC." | 1.31 | Osteoporosis in primary biliary cirrhosis revisited. ( Bassendine, M; Francis, R; James, O; Jones, D; Newton, J; Prince, M; Rawlings, D, 2001) |
| " The dosage of the steroid, life style factors, menopausal status, low bone mineral density at baseline and previous osteoporotic fractures predispose for the manifestation of steroid-induced osteoporosis." | 1.31 | [Risk of osteoporosis in steroid therapy. When and how to counter the risk]. ( Aschl, G; Hinterreiter, M; Kirchgatterer, A; Knoflach, P, 2001) |
| "Osteoporosis is a common disease among patients undergoing transplantation and a loss of bone mass is usually detected after bone marrow transplantation (BMT), particularly during the immediate post-BMT period." | 1.31 | The role of cytokines in the changes in bone turnover following bone marrow transplantation. ( Cha, BY; Han, JH; Kang, MI; Kang, SK; Kim, CC; Lee, KW; Lee, WY; Oh, ES; Oh, KW; Son, HY, 2002) |
| "However, the role of bone resorption in the initial rapid phase of bone loss characteristic of glucocorticoid-induced osteoporosis is unexplained, and the reason for the efficacy of bisphosphonates in this condition remains unknown." | 1.31 | Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. ( Bellido, T; Chen, JR; Jilka, RL; Landes, RD; Manolagas, SC; Parfitt, AM; Powers, CC; Stewart, SA; Weinstein, RS, 2002) |
| "The purpose of this study was to examine the relationship of cumulative steroid dosage and duration of therapy with osteoporosis." | 1.29 | Osteoporosis in steroid-dependent asthma. ( Gordon, EH; Hahn, TJ; Klaustermeyer, WB; Villareal, MS, 1996) |
| "Two paediatric patients with systemic lupus erythematosus were treated with immunoglobulin G (IgG)." | 1.27 | IgG therapy in systemic lupus erythematosus--two case reports. ( Dopfer, R; Gaedicke, G; Kohne, E; Niethammer, D; Teller, WM, 1984) |
| "The diagnosis of Crohn's disease with extensive involvement of small intestine and colon was first made in a 12 3/4-year-old girl, now 15 1/2 years old." | 1.27 | [Crohn disease: initial experiences with cyclosporin A in an adolescent girl]. ( Dannecker, G; Malchow, H; Niessen, KH; Ranke, MB, 1985) |
| " Prednisolone therapy in 22 patients (mean dosage 8 mg/day) was associated with reductions in estrone and testosterone levels; however, DHEAS and femoral BMD were also decreased in RA patients who were not receiving corticosteroids." | 1.27 | Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. ( Champion, GD; Eisman, JA; Pocock, NA; Sambrook, PN, 1988) |
| "Bone resorption was monitored by measuring urinary hydroxyproline excretion." | 1.27 | Effects of NaCl on calcium balance, parathyroid function and hydroxyproline excretion in prednisolone-treated rats consuming low calcium diet. ( Goulding, A; McIntosh, J, 1986) |
| "Osteoporosis is a common complication of corticosteroid therapy and it is associated with both decreased bone formation and increased bone resorption." | 1.27 | Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women. ( Hartley, TF; Need, AG; Nordin, BE; Philcox, JC, 1986) |
| " Prednisolone (mean dosage 8 mg/day) was not associated with significantly increased bone loss in women, whereas higher dosages in men (mean 10." | 1.27 | Determinants of axial bone loss in rheumatoid arthritis. ( Champion, GD; Eberl, S; Eisman, JA; Pocock, NA; Sambrook, PN; Yeates, MG, 1987) |
| " The dosage of 4." | 1.25 | On the effect of prednisolone on hamster bone. ( Bühler, G; Lindenhayn, K; Mühlbach, R, 1975) |
| "Treatment with Prednisolone(R) did not change the magnitude of the initial response to 1,25-dihydroxyvitamin D(3) at 7 hr, but did decrease the response at 24 and 48 hr after a single dose of 1,25-dihydroxyvitamin D(3)." | 1.25 | The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3. ( Ayigbedé, O; Carré, M; Miravet, L; Rasmussen, H, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 74 (26.71) | 18.7374 |
| 1990's | 34 (12.27) | 18.2507 |
| 2000's | 93 (33.57) | 29.6817 |
| 2010's | 70 (25.27) | 24.3611 |
| 2020's | 6 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Yamasaki, S | 1 |
| Fu, SQ | 1 |
| Wang, ZY | 2 |
| Jiang, ZM | 2 |
| Bi, ZM | 1 |
| Liu, EH | 2 |
| Liu, WJ | 1 |
| Chen, Y | 1 |
| Xiao, PT | 1 |
| Huang, TQ | 1 |
| Swami, T | 1 |
| Molloy, C | 1 |
| Keyßer, G | 1 |
| Li, C | 1 |
| Yang, P | 1 |
| Liu, B | 2 |
| Bu, J | 1 |
| Liu, H | 2 |
| Guo, J | 2 |
| Hasegawa, T | 2 |
| Si, H | 1 |
| Li, M | 4 |
| Nakamura, Y | 1 |
| Suzuki, T | 1 |
| Yoshida, T | 1 |
| Yamazaki, H | 1 |
| Kato, H | 1 |
| Emamifar, A | 1 |
| Hess, S | 1 |
| Gerke, O | 1 |
| Hermann, AP | 1 |
| Laustrup, H | 1 |
| Hansen, PS | 1 |
| Thye-Rønn, P | 1 |
| Marcussen, N | 1 |
| Svendstrup, F | 1 |
| Gildberg-Mortensen, R | 1 |
| Bang, JC | 1 |
| Farahani, ZA | 1 |
| Chrysidis, S | 1 |
| Toftegaard, P | 1 |
| Andreasen, RA | 1 |
| le Greves, S | 1 |
| Andersen, HR | 1 |
| Olsen, RN | 1 |
| Hansen, IMJ | 1 |
| Yeo, PM | 1 |
| Ang, CC | 1 |
| Ohlsson, C | 1 |
| Nilsson, KH | 1 |
| Henning, P | 1 |
| Wu, J | 1 |
| Gustafsson, KL | 1 |
| Poutanen, M | 1 |
| Lerner, UH | 1 |
| Movérare-Skrtic, S | 1 |
| Iseri, K | 1 |
| Iyoda, M | 1 |
| Watanabe, M | 1 |
| Matsumoto, K | 1 |
| Sanada, D | 1 |
| Inoue, T | 2 |
| Tachibana, S | 1 |
| Shibata, T | 1 |
| He, H | 1 |
| Wang, C | 1 |
| Tang, Q | 1 |
| Yang, F | 2 |
| Xu, Y | 1 |
| van Bommel, EJM | 1 |
| de Jongh, RT | 1 |
| Brands, M | 1 |
| Heijboer, AC | 1 |
| den Heijer, M | 1 |
| Serlie, MJ | 1 |
| van Raalte, DH | 1 |
| Suda, M | 1 |
| Suyama, Y | 1 |
| Ohde, S | 1 |
| Tsuda, T | 1 |
| Sawada, H | 1 |
| Kishimoto, M | 1 |
| Okada, M | 1 |
| Ishida, T | 2 |
| Yoshida, S | 1 |
| Kimura, Y | 1 |
| Fujiki, Y | 1 |
| Kotani, T | 1 |
| Takeuchi, T | 1 |
| Makino, S | 1 |
| Arawaka, S | 1 |
| Lin, JB | 1 |
| Wu, H | 1 |
| Liu, YL | 1 |
| Shaw, PC | 1 |
| Li, PB | 1 |
| Zhu, W | 1 |
| Ding, W | 1 |
| Shang, X | 1 |
| Zhu, D | 1 |
| Dai, X | 1 |
| Lin, ZW | 1 |
| Huang, TY | 1 |
| Chen, TT | 1 |
| Cui, J | 2 |
| Li, MY | 1 |
| Hua, YQ | 1 |
| Mitani, Y | 1 |
| Helliwell, T | 1 |
| Hider, SL | 1 |
| Mallen, CD | 1 |
| Nadesalingam, K | 1 |
| Kirby, D | 1 |
| de Vrieze, E | 1 |
| van Kessel, MA | 1 |
| Peters, HM | 1 |
| Spanings, FA | 1 |
| Flik, G | 1 |
| Metz, JR | 1 |
| Ochi, K | 1 |
| Go, Y | 1 |
| Furuya, T | 1 |
| Ikari, K | 1 |
| Taniguchi, A | 1 |
| Yamanaka, H | 1 |
| Momohara, S | 2 |
| Suzuki, Y | 2 |
| Banji, D | 1 |
| Banji, OJ | 1 |
| Chiluka, VL | 1 |
| Abbagoni, S | 1 |
| Muso, E | 1 |
| Santiago, T | 1 |
| da Silva, JA | 1 |
| Saag, KG | 1 |
| Soen, S | 3 |
| Jing, LJ | 1 |
| Wang, CM | 1 |
| Wei, YJ | 1 |
| Jia, XB | 1 |
| Xie, L | 1 |
| Park, S | 1 |
| Oh, J | 1 |
| Son, KY | 1 |
| Cho, KO | 1 |
| Choi, J | 1 |
| Pasqualetti, S | 2 |
| Congiu, T | 1 |
| Banfi, G | 2 |
| Mariotti, M | 2 |
| Chen, SJ | 1 |
| Liao, WC | 1 |
| Huang, KH | 1 |
| Lin, CL | 1 |
| Tsai, WC | 1 |
| Kung, PT | 1 |
| Chang, KH | 1 |
| Kao, CH | 1 |
| Mok, CC | 2 |
| Ho, LY | 1 |
| Ma, KM | 2 |
| Rocha, A | 1 |
| Martins, LS | 1 |
| Malheiro, J | 1 |
| Dores, J | 1 |
| Santos, C | 1 |
| Henriques, C | 1 |
| Abell, S | 1 |
| Zeimer, H | 1 |
| Chong, A | 1 |
| MacIsaac, RJ | 1 |
| Krishnamoorthy, TL | 1 |
| Miezynska-Kurtycz, J | 1 |
| Hodson, J | 1 |
| Gunson, BK | 1 |
| Neuberger, J | 1 |
| Milkiewicz, P | 1 |
| Oo, YH | 1 |
| Sun, B | 1 |
| Sun, J | 1 |
| Han, X | 1 |
| Li, J | 1 |
| Du, J | 1 |
| Feng, W | 1 |
| Amizuka, N | 2 |
| Chandy, DD | 1 |
| Bhatia, E | 1 |
| Carnovali, M | 1 |
| Ottria, R | 1 |
| Ciuffreda, P | 1 |
| Krasselt, M | 1 |
| Baerwald, C | 1 |
| Li, X | 1 |
| Zhou, ZY | 1 |
| Zhang, YY | 1 |
| Yang, HL | 1 |
| Ceccato, F | 1 |
| Barbot, M | 1 |
| Albiger, N | 1 |
| Zilio, M | 1 |
| De Toni, P | 1 |
| Luisetto, G | 1 |
| Zaninotto, M | 1 |
| Greggio, NA | 1 |
| Boscaro, M | 1 |
| Scaroni, C | 1 |
| Camozzi, V | 1 |
| Perera, N | 1 |
| Sampaio, H | 1 |
| Woodhead, H | 1 |
| Farrar, M | 1 |
| Huang, Y | 1 |
| Bo, Y | 1 |
| Wu, X | 1 |
| Wang, Q | 1 |
| Qin, F | 1 |
| Zhao, L | 1 |
| Xiong, Z | 2 |
| Ersek, A | 1 |
| Santo, AI | 1 |
| Vattakuzhi, Y | 1 |
| George, S | 1 |
| Clark, AR | 1 |
| Horwood, NJ | 1 |
| Wilson, JC | 2 |
| Sarsour, K | 2 |
| Collinson, N | 2 |
| Tuckwell, K | 2 |
| Musselman, D | 2 |
| Klearman, M | 2 |
| Napalkov, P | 2 |
| Jick, SS | 2 |
| Stone, JH | 2 |
| Meier, CR | 2 |
| Noguchi, T | 1 |
| Ebina, K | 1 |
| Hirao, M | 1 |
| Morimoto, T | 1 |
| Koizumi, K | 1 |
| Kitaguchi, K | 1 |
| Matsuoka, H | 1 |
| Iwahashi, T | 1 |
| Yoshikawa, H | 1 |
| Ashida, A | 1 |
| Fujii, Y | 1 |
| Matsumura, H | 1 |
| Tamai, H | 1 |
| Ogoshi, T | 1 |
| Hagino, H | 1 |
| Fukata, S | 1 |
| Tanishima, S | 1 |
| Okano, T | 1 |
| Teshima, R | 1 |
| Okada, Y | 1 |
| Nawata, M | 1 |
| Nakayamada, S | 1 |
| Saito, K | 1 |
| Tanaka, Y | 2 |
| Kozai, Y | 1 |
| Kawamata, R | 1 |
| Sakurai, T | 1 |
| Kanno, M | 1 |
| Kashima, I | 1 |
| Ng, KP | 1 |
| Ramos, F | 1 |
| Sultan, SM | 1 |
| Isenberg, DA | 1 |
| Hofbauer, LC | 2 |
| Zeitz, U | 1 |
| Schoppet, M | 1 |
| Skalicky, M | 1 |
| Schüler, C | 1 |
| Stolina, M | 1 |
| Kostenuik, PJ | 1 |
| Erben, RG | 1 |
| Kriel, MH | 1 |
| Tobias, JH | 1 |
| Creed, TJ | 1 |
| Lockett, M | 1 |
| Linehan, J | 1 |
| Bell, A | 1 |
| Przemioslo, R | 1 |
| Smithson, JE | 1 |
| Brooklyn, TN | 1 |
| Fraser, WD | 1 |
| Probert, CS | 1 |
| Tsujikawa, T | 1 |
| Andoh, A | 1 |
| Inatomi, O | 1 |
| Bamba, S | 1 |
| Nakahara, T | 1 |
| Sasaki, M | 1 |
| Saito, H | 1 |
| Fujiyama, Y | 1 |
| Niiyama, S | 1 |
| Amoh, Y | 1 |
| Suzuki, K | 1 |
| Wada, T | 1 |
| Katsuoka, K | 1 |
| Krüger, A | 1 |
| Hamann, C | 1 |
| Brendel, C | 1 |
| Ramaswamy, A | 1 |
| Schnabel, M | 1 |
| Neubauer, A | 1 |
| Ahmadpoor, P | 1 |
| Reisi, S | 1 |
| Makhdoomi, K | 1 |
| Ghafari, A | 1 |
| Sepehrvand, N | 1 |
| Rahimi, E | 1 |
| Dasgupta, B | 2 |
| Borg, FA | 1 |
| Hassan, N | 1 |
| Barraclough, K | 1 |
| Bourke, B | 1 |
| Fulcher, J | 1 |
| Hollywood, J | 1 |
| Hutchings, A | 1 |
| Kyle, V | 1 |
| Nott, J | 1 |
| Power, M | 1 |
| Samanta, A | 1 |
| Kaji, H | 1 |
| Kuroki, Y | 1 |
| Murakawa, Y | 1 |
| Funakawa, I | 1 |
| Funasaka, Y | 1 |
| Kanda, F | 1 |
| Sugimoto, T | 2 |
| Iakupov, RR | 1 |
| Rakhmatullin, FA | 1 |
| Kaiumov, FA | 1 |
| Ibatullina, RB | 1 |
| Chia, FL | 1 |
| Thong, BY | 1 |
| Lau, TC | 1 |
| Feng, PH | 1 |
| Phillips, PJ | 1 |
| Burnet, S | 1 |
| Takei, T | 1 |
| Itabashi, M | 1 |
| Tsukada, M | 1 |
| Sugiura, H | 1 |
| Moriyama, T | 1 |
| Kojima, C | 1 |
| Shiohira, S | 1 |
| Shimizu, A | 1 |
| Karasawa, K | 1 |
| Amemiya, N | 1 |
| Kawanishi, K | 1 |
| Ogawa, T | 1 |
| Uchida, K | 1 |
| Tsuchiya, K | 1 |
| Nitta, K | 1 |
| Li, EK | 2 |
| Zhu, TY | 2 |
| Hung, VY | 1 |
| Kwok, AW | 2 |
| Lee, VW | 1 |
| Lee, KK | 1 |
| Griffith, JF | 2 |
| Wong, KC | 1 |
| Leung, PC | 2 |
| Qin, L | 2 |
| Tam, LS | 2 |
| Miyakoshi, N | 1 |
| Sasaki, H | 1 |
| Kasukawa, Y | 1 |
| Kamo, K | 1 |
| Shimada, Y | 1 |
| Ahmed, HH | 2 |
| Morcos, NY | 2 |
| Eskander, EF | 2 |
| Seoudi, DM | 2 |
| Shalby, AB | 2 |
| Saito, M | 1 |
| Marumo, K | 1 |
| Ushiku, C | 1 |
| Kato, S | 1 |
| Sakai, S | 1 |
| Hayakawa, N | 2 |
| Mihara, M | 1 |
| Shiraishi, A | 2 |
| Eiken, PA | 2 |
| Hansen, M | 1 |
| Kristensen, B | 1 |
| Langdahl, BL | 2 |
| Abrahamsen, B | 2 |
| Fujita, Y | 1 |
| Watanabe, K | 1 |
| Uchikanbori, S | 1 |
| Maki, K | 1 |
| Fessel, WJ | 1 |
| Chau, Q | 1 |
| Leong, D | 1 |
| Maher, JR | 1 |
| Takahata, M | 1 |
| Awad, HA | 1 |
| Berger, AJ | 1 |
| Koetz, KR | 1 |
| Ventz, M | 1 |
| Diederich, S | 1 |
| Quinkler, M | 1 |
| Folwarczna, J | 1 |
| Pytlik, M | 1 |
| Sliwiński, L | 1 |
| Cegieła, U | 1 |
| Nowińska, B | 1 |
| Rajda, M | 1 |
| Tee, SI | 1 |
| Yosipovitch, G | 1 |
| Chan, YC | 1 |
| Chua, SH | 1 |
| Koh, ET | 1 |
| Chan, YH | 1 |
| Tan, SS | 1 |
| Tsou, IY | 1 |
| Tan, SH | 1 |
| Liu, X | 1 |
| Zhang, S | 1 |
| Lu, X | 1 |
| Zheng, S | 1 |
| Li, F | 2 |
| Takagi, S | 1 |
| Komatsu, N | 1 |
| Albrecht, J | 1 |
| Werth, VP | 1 |
| Kaczmarczyk-Sedlak, I | 1 |
| Zych, M | 1 |
| Rotko, K | 1 |
| Sedlak, L | 1 |
| Tang, XL | 1 |
| Kun, EW | 1 |
| Hung, VW | 1 |
| Brask-Lindemann, D | 1 |
| Vestbo, J | 1 |
| Musumeci, G | 1 |
| Loreto, C | 1 |
| Leonardi, R | 1 |
| Castorina, S | 1 |
| Giunta, S | 1 |
| Carnazza, ML | 1 |
| Trovato, FM | 1 |
| Pichler, K | 1 |
| Weinberg, AM | 1 |
| Prasad, R | 1 |
| De Silva, M | 1 |
| Tsugeno, H | 2 |
| Fujita, T | 1 |
| Goto, B | 1 |
| Sugishita, T | 1 |
| Hosaki, Y | 1 |
| Ashida, K | 1 |
| Mitsunobu, F | 1 |
| Tanizaki, Y | 1 |
| Shiratori, Y | 1 |
| de Jong, DJ | 1 |
| Corstens, FH | 1 |
| Mannaerts, L | 1 |
| van Rossum, LG | 1 |
| Naber, AH | 1 |
| Jones, NP | 1 |
| Anderton, LC | 1 |
| Cheong, FM | 1 |
| Whallett, A | 1 |
| Stanford, MR | 1 |
| Murray, PI | 1 |
| Lesnik-Oberstein, S | 1 |
| Pavesio, C | 1 |
| Walsh, LJ | 2 |
| Lewis, SA | 1 |
| Wong, CA | 2 |
| Cooper, S | 1 |
| Oborne, J | 1 |
| Cawte, SA | 1 |
| Harrison, T | 1 |
| Green, DJ | 1 |
| Pringle, M | 2 |
| Hubbard, R | 1 |
| Tattersfield, AE | 2 |
| Gordon, MM | 1 |
| Stevenson, S | 1 |
| Hunter, JA | 1 |
| Nakamura, T | 2 |
| Maekawa, S | 1 |
| Morinobu, S | 1 |
| Morinobu, A | 1 |
| Koshiba, M | 1 |
| Yamauchi, M | 1 |
| Kumagai, S | 1 |
| van Staa, TP | 1 |
| Leufkens, HG | 1 |
| Cooper, C | 1 |
| Ponteggia, M | 1 |
| Ponteggia, F | 1 |
| Di Cato, L | 1 |
| Puxeddu, A | 1 |
| Coaccioli, S | 1 |
| van den Ham, EC | 1 |
| Kooman, JP | 1 |
| Christiaans, ML | 1 |
| van Hooff, JP | 1 |
| Kosch, M | 1 |
| Kisters, K | 1 |
| Hausberg, M | 1 |
| Li, Y | 1 |
| Xu, L | 1 |
| Shen, L | 1 |
| Yu, L | 1 |
| Chen, L | 1 |
| Höfle, G | 1 |
| Holzmüller, H | 1 |
| Gouya, G | 1 |
| Hergan, K | 1 |
| Hubmann, M | 1 |
| Langer, P | 1 |
| Drexel, H | 1 |
| Antelava, OA | 1 |
| Smirnov, AV | 1 |
| Demin, NV | 1 |
| Khitrov, AN | 1 |
| Benevolenskaia, LI | 1 |
| Nasonov, EL | 1 |
| Beglinger, Ch | 1 |
| Celiker, R | 1 |
| Bal, S | 1 |
| Bakkaloğlu, A | 1 |
| Ozaydin, E | 1 |
| Coskun, T | 1 |
| Cetin, A | 1 |
| Dinçer, F | 1 |
| Mirzaei, S | 1 |
| Zajicek, HK | 1 |
| Knoll, P | 1 |
| Hahn, M | 1 |
| Levi, M | 1 |
| Köhn, H | 1 |
| Pohl, W | 1 |
| Miah, S | 1 |
| Taylor, R | 1 |
| McKellar, G | 1 |
| Hunter, J | 1 |
| HENNE, HF | 1 |
| GARCES CUADRA, O | 1 |
| TAKAYAMA, A | 1 |
| OGUMA, Y | 1 |
| YAMANAKA, K | 1 |
| HEATHER, AJ | 1 |
| CHARPIN, J | 1 |
| PAYAN, H | 1 |
| LUCCIONI, R | 1 |
| LIEUTAUD, R | 1 |
| OHRESSER, P | 1 |
| NICOLINO, J | 1 |
| SCHMID, J | 1 |
| MYKHAMEDZIANOVA, GS | 1 |
| TREADWELL, BL | 1 |
| SEVER, ED | 1 |
| SAVAGE, O | 1 |
| COPEMAN, WS | 1 |
| AMANN, E | 1 |
| SALEM, G | 1 |
| DVORSZKY, K | 1 |
| CSEPLAK, G | 1 |
| Robson, P | 1 |
| Hughes, A | 1 |
| Orozco, P | 1 |
| Zwart, M | 1 |
| Pufe, T | 1 |
| Scholz-Ahrens, KE | 1 |
| Franke, AT | 1 |
| Petersen, W | 1 |
| Mentlein, R | 1 |
| Varoga, D | 1 |
| Tillmann, B | 1 |
| Schrezenmeir, J | 1 |
| Glüer, CC | 1 |
| Weinstein, RS | 3 |
| Jia, D | 1 |
| Powers, CC | 2 |
| Stewart, SA | 2 |
| Jilka, RL | 3 |
| Parfitt, AM | 3 |
| Manolagas, SC | 3 |
| Dolan, AL | 1 |
| Koshy, E | 1 |
| Waker, M | 1 |
| Goble, CM | 1 |
| Naunton, M | 2 |
| Peterson, GM | 1 |
| Jones, G | 1 |
| Griffin, GM | 1 |
| Bleasel, MD | 1 |
| Wakata, N | 1 |
| Nemoto, H | 1 |
| Sugimoto, H | 1 |
| Nomoto, N | 1 |
| Konno, S | 1 |
| Hayashi, N | 1 |
| Araki, Y | 1 |
| Nakazato, A | 1 |
| Shimojima, Y | 1 |
| Gono, T | 1 |
| Yamamoto, K | 1 |
| Hoshi, K | 1 |
| Matsuda, M | 1 |
| Yoshida, K | 1 |
| Ikeda, S | 2 |
| Forrest, CM | 1 |
| Kennedy, A | 1 |
| Stone, TW | 1 |
| Stoy, N | 1 |
| Darlington, LG | 1 |
| Noa, M | 1 |
| Mendoza, S | 1 |
| Más, R | 1 |
| Mendoza, N | 1 |
| León, F | 1 |
| Okada, N | 1 |
| Tanaka, I | 1 |
| Oshima, H | 1 |
| Yee, CS | 1 |
| Crabtree, N | 1 |
| Skan, J | 1 |
| Amft, N | 1 |
| Bowman, S | 1 |
| Situnayake, D | 1 |
| Gordon, C | 1 |
| Schoon, EJ | 1 |
| Bollani, S | 2 |
| Mills, PR | 1 |
| Israeli, E | 1 |
| Felsenberg, D | 1 |
| Ljunghall, S | 1 |
| Persson, T | 1 |
| Haptén-White, L | 1 |
| Graffner, H | 1 |
| Bianchi Porro, G | 2 |
| Vatn, M | 1 |
| Stockbrügger, RW | 1 |
| Wissing, KM | 1 |
| Broeders, N | 1 |
| Moreno-Reyes, R | 1 |
| Gervy, C | 1 |
| Stallenberg, B | 1 |
| Abramowicz, D | 1 |
| Sohen, S | 1 |
| Rødevand, E | 1 |
| Mikkelsen, K | 1 |
| Nordvåg, BY | 1 |
| Haga, HJ | 1 |
| Førre, Ø | 1 |
| Johnsen, V | 1 |
| Kvien, TK | 1 |
| Bassingthwaighte, C | 1 |
| Akahoshi, S | 1 |
| Sakai, A | 1 |
| Arita, S | 1 |
| Morishita, Y | 1 |
| Tsutsumi, H | 1 |
| Ito, M | 1 |
| Alikasifoglu, A | 1 |
| Yetgin, S | 1 |
| Cetin, M | 1 |
| Tuncer, M | 1 |
| Gumruk, F | 1 |
| Gurgey, A | 1 |
| Yordam, N | 1 |
| Fassbender, WJ | 1 |
| Abreu, MT | 1 |
| Fujii, N | 1 |
| Hamano, T | 1 |
| Isaka, Y | 1 |
| Ito, T | 1 |
| Imai, E | 1 |
| Naiki, Y | 1 |
| Tanaka, T | 1 |
| Bak, M | 1 |
| Serdaroglu, E | 1 |
| Guclu, R | 1 |
| Hasegawa, M | 1 |
| Nisikawa, M | 1 |
| Nomura, S | 1 |
| Takubo, T | 1 |
| Suehiro, A | 1 |
| Saigo, K | 1 |
| Hayashi, K | 1 |
| Tamaki, S | 1 |
| Mizutani, M | 1 |
| Uemura, Y | 1 |
| Kurata, Y | 1 |
| Bird, S | 1 |
| Kanehara, M | 1 |
| Ogirima, T | 1 |
| Tano, K | 1 |
| Maenaka, T | 1 |
| Zhang, B | 1 |
| Li, G | 1 |
| Wang, X | 1 |
| Guo, Y | 1 |
| Subrahmanyan, P | 1 |
| Panayotakopoulos, GD | 1 |
| Day, S | 1 |
| Peters, BS | 1 |
| Kulasegaram, R | 1 |
| Duyvendak, M | 1 |
| Atthobari, J | 1 |
| van den Berg, PB | 1 |
| Brouwers, JR | 1 |
| Ungprasert, S | 1 |
| Wangkaew, S | 1 |
| Louthrenoo, W | 1 |
| Söderpalm, AC | 1 |
| Magnusson, P | 1 |
| Ahlander, AC | 1 |
| Karlsson, J | 1 |
| Kroksmark, AK | 1 |
| Tulinius, M | 1 |
| Swolin-Eide, D | 1 |
| Tong, KH | 1 |
| To, CH | 1 |
| Siu, YP | 1 |
| Morishita, M | 1 |
| Nagashima, M | 1 |
| Wauke, K | 1 |
| Takahashi, H | 1 |
| Takenouchi, K | 1 |
| Saito, T | 1 |
| Goldie, I | 1 |
| Tibblin, G | 1 |
| Scheller, S | 1 |
| Robin, JC | 3 |
| Ambrus, JL | 4 |
| Pines, A | 1 |
| Raafat, H | 1 |
| Lynn, AH | 1 |
| Whittington, J | 1 |
| Lindgren, JU | 1 |
| DeLuca, HF | 1 |
| Mazess, RB | 1 |
| Lyn, PC | 1 |
| Hajiroussou, VJ | 1 |
| Webley, M | 1 |
| Gaedicke, G | 1 |
| Teller, WM | 1 |
| Kohne, E | 1 |
| Dopfer, R | 1 |
| Niethammer, D | 1 |
| Reid, DM | 2 |
| Kennedy, NS | 1 |
| Smith, MA | 2 |
| Tothill, P | 2 |
| Nuki, G | 2 |
| Lombardi, V | 1 |
| Di Giovanni, T | 1 |
| Zizza, F | 1 |
| Kaladze, NN | 1 |
| Pokatilova, VE | 1 |
| Skingle, SJ | 1 |
| Crisp, AJ | 1 |
| Aritomi, H | 1 |
| Hattersley, AT | 1 |
| Meeran, K | 1 |
| Burrin, J | 1 |
| Hill, P | 1 |
| Shiner, R | 1 |
| Ibbertson, HK | 1 |
| Oka, K | 1 |
| Shimodaira, H | 1 |
| Hirano, T | 1 |
| Sakurai, E | 1 |
| Tamaki, T | 1 |
| Kozaki, M | 1 |
| Rico, H | 1 |
| Villa, LF | 1 |
| Clemens, MR | 1 |
| Fessele, K | 1 |
| Heim, ME | 1 |
| Villareal, MS | 1 |
| Klaustermeyer, WB | 1 |
| Hahn, TJ | 1 |
| Gordon, EH | 1 |
| Kirwan, JR | 1 |
| Lim, KK | 1 |
| Staun, M | 1 |
| Tjellesen, L | 1 |
| Thale, M | 1 |
| Schaadt, O | 1 |
| Jarnum, S | 1 |
| Otsuka, F | 1 |
| Ogura, T | 1 |
| Kataoka, H | 1 |
| Kawashima, M | 1 |
| Mimura, Y | 1 |
| Yamauchi, T | 1 |
| Kashihara, N | 1 |
| Kageyama, J | 1 |
| Makino, H | 1 |
| Boutsen, Y | 2 |
| Jamart, J | 2 |
| Esselinckx, W | 2 |
| Stoffel, M | 1 |
| Devogelaer, JP | 4 |
| Bijlsma, JW | 1 |
| Wimalawansa, SJ | 1 |
| Simmons, DJ | 1 |
| Kin, Y | 1 |
| Sawada, Y | 1 |
| Onishi, K | 1 |
| Eto, A | 1 |
| Taka, K | 1 |
| Yokota, Y | 1 |
| Kosasa, T | 1 |
| Yamamura, M | 1 |
| Satomi, T | 1 |
| Yamashita, T | 1 |
| Nishikami, T | 1 |
| Pearce, G | 1 |
| Ryan, PF | 1 |
| Delmas, PD | 1 |
| Tabensky, DA | 1 |
| Seeman, E | 1 |
| Herrala, J | 1 |
| Puolijoki, H | 1 |
| Liippo, K | 1 |
| Raitio, M | 1 |
| Impivaara, O | 1 |
| Tala, E | 1 |
| Nieminen, MM | 1 |
| Pitt, P | 1 |
| Todd, P | 1 |
| Webber, D | 1 |
| Pack, S | 1 |
| Moniz, C | 1 |
| Compston, JE | 2 |
| Reginster, JY | 1 |
| Kuntz, D | 1 |
| Verdickt, W | 1 |
| Wouters, M | 1 |
| Guillevin, L | 1 |
| Menkès, CJ | 1 |
| Nielsen, K | 1 |
| Matsuda, K | 1 |
| Watanabe, T | 1 |
| Abo, Y | 1 |
| Uchida, H | 1 |
| Kawamura, YJ | 1 |
| Masaki, T | 1 |
| Muto, T | 1 |
| Kashyap, AS | 1 |
| Kashyap, S | 1 |
| Ememl'ianov, AV | 1 |
| Shevelev, SE | 1 |
| Murzin, BA | 1 |
| Amosov, VI | 1 |
| Yonemura, K | 1 |
| Kimura, M | 1 |
| Miyaji, T | 1 |
| Hishida, A | 1 |
| Ardizzone, S | 1 |
| Bettica, P | 1 |
| Bevilacqua, M | 1 |
| Molteni, P | 1 |
| Rooney, M | 1 |
| Davies, UM | 1 |
| Reeve, J | 1 |
| Preece, M | 1 |
| Ansell, BM | 1 |
| Woo, PM | 1 |
| Eastell, R | 1 |
| Peel, NF | 1 |
| Chines, AA | 1 |
| Bax, DE | 1 |
| Sacco-Gibson, N | 1 |
| Nagant de Deuxchaisnes, C | 1 |
| Russell, RG | 1 |
| Ozaki, D | 1 |
| Shirai, Y | 1 |
| Nakayama, Y | 1 |
| Uesaka, S | 1 |
| Lezhnina, MB | 1 |
| Lesniak, OM | 1 |
| Piven', AI | 1 |
| Lebedeva, MK | 1 |
| Hamburg, SM | 1 |
| Piers, DA | 1 |
| van den Berg, AP | 1 |
| Slooff, MJ | 1 |
| Haagsma, EB | 1 |
| Smith, GD | 1 |
| Stevens, DL | 1 |
| Fuller, GN | 1 |
| Ugur, A | 1 |
| Guvener, N | 1 |
| Işiklar, I | 1 |
| Turan, M | 1 |
| Erdal, R | 1 |
| Haberal, M | 1 |
| Sambrook, P | 1 |
| Raj, A | 1 |
| Hunter, D | 1 |
| Naganathan, V | 1 |
| Mason, R | 1 |
| Robinson, B | 1 |
| Goffin, E | 1 |
| Depresseux, G | 1 |
| Squifflet, JP | 1 |
| Pirson, Y | 1 |
| Sugiyama, T | 1 |
| Matsubara, T | 1 |
| Kawai, S | 1 |
| Furukawa, S | 1 |
| Newton, J | 1 |
| Francis, R | 1 |
| Prince, M | 1 |
| James, O | 1 |
| Bassendine, M | 1 |
| Rawlings, D | 1 |
| Jones, D | 1 |
| Kirchgatterer, A | 1 |
| Aschl, G | 1 |
| Hinterreiter, M | 1 |
| Knoflach, P | 1 |
| Karcic, E | 1 |
| Karcic, AA | 1 |
| Matsumoto, H | 1 |
| Ishihara, K | 1 |
| Umeda, B | 1 |
| Niimi, A | 1 |
| Hino, M | 1 |
| Holtmeier, J | 1 |
| Leuschner, U | 1 |
| Rau, R | 1 |
| Lee, WY | 1 |
| Kang, MI | 1 |
| Oh, ES | 1 |
| Oh, KW | 1 |
| Han, JH | 1 |
| Cha, BY | 1 |
| Lee, KW | 1 |
| Son, HY | 1 |
| Kang, SK | 1 |
| Kim, CC | 1 |
| Hart, SR | 1 |
| Green, B | 1 |
| Chen, JR | 1 |
| Landes, RD | 1 |
| Bellido, T | 1 |
| Eguchi, K | 1 |
| Dubois, EF | 1 |
| Röder, E | 1 |
| Dekhuijzen, PN | 1 |
| Zwinderman, AE | 1 |
| Schweitzer, DH | 1 |
| Loddenkemper, K | 1 |
| Perka, C | 1 |
| Burmester, GR | 1 |
| Buttgereit, F | 1 |
| Crilly, RG | 1 |
| Marshall, DH | 1 |
| Nordin, BE | 3 |
| Condon, JR | 1 |
| Nassim, JR | 1 |
| Dent, CE | 1 |
| Hilb, A | 1 |
| Stainthorpe, EM | 1 |
| Goodman, M | 1 |
| Solomons, CC | 1 |
| Miller, PD | 1 |
| Telegina, ND | 1 |
| Shogam, IA | 1 |
| Kratinov, VP | 1 |
| Rutshteĭn, LG | 1 |
| Briskin, AI | 1 |
| Liapon, AO | 1 |
| Kelly, RS | 1 |
| Mannley, N | 1 |
| Thomas, CC | 1 |
| Naghavi, M | 1 |
| Mesgarzadeh, DD | 1 |
| Lindenhayn, K | 2 |
| Bühler, G | 2 |
| Mühlbach, R | 1 |
| Wells, AU | 1 |
| Elomaa, I | 1 |
| Virkkunen, P | 1 |
| Risteli, L | 1 |
| Risteli, J | 1 |
| Gallacher, SJ | 1 |
| Fenner, JA | 1 |
| Anderson, K | 1 |
| Adamson, BB | 1 |
| Banham, SW | 1 |
| Boyle, IT | 1 |
| Swissa-Sivan, A | 1 |
| Statter, M | 1 |
| Brooks, GA | 1 |
| Azevedo, J | 1 |
| Viguie, C | 1 |
| Azoury, R | 1 |
| Greenfield, C | 1 |
| Oman, S | 1 |
| Leichter, I | 1 |
| Zinker, BA | 1 |
| Jennings, BH | 1 |
| Andersson, KE | 1 |
| Johansson, SA | 1 |
| Iwasaki, T | 1 |
| Curley, RK | 1 |
| Holden, CA | 1 |
| Mizushima, Y | 1 |
| Torikai, K | 1 |
| Nakatsuka, K | 1 |
| Nishizawa, Y | 1 |
| Hagiwara, S | 1 |
| Koyama, H | 1 |
| Miki, T | 1 |
| Ochi, H | 1 |
| Morii, H | 1 |
| Trzenschik, K | 1 |
| David, L | 1 |
| Hughes, GR | 1 |
| Aroso Dias, A | 1 |
| Lopes Vaz, A | 1 |
| Hargreaves, M | 1 |
| Afonso, C | 1 |
| Araújø, D | 1 |
| Bravo, T | 1 |
| Sambrook, PN | 4 |
| Cohen, ML | 1 |
| Eisman, JA | 4 |
| Pocock, NA | 4 |
| Champion, GD | 4 |
| Yeates, MG | 3 |
| Peretz, A | 1 |
| Praet, JP | 1 |
| Bosson, D | 1 |
| Rozenberg, S | 1 |
| Bourdoux, P | 1 |
| Yamada, H | 1 |
| Takeo, Y | 1 |
| Tominaga, K | 1 |
| Tsuji, H | 1 |
| Yoh, K | 1 |
| Nakano, K | 1 |
| Kruse, K | 1 |
| Büsse, M | 1 |
| Kracht, U | 1 |
| Kruse, U | 1 |
| Wohlfart, K | 1 |
| Dannecker, G | 1 |
| Malchow, H | 1 |
| Niessen, KH | 1 |
| Ranke, MB | 1 |
| Goulding, A | 1 |
| McIntosh, J | 1 |
| Need, AG | 1 |
| Philcox, JC | 1 |
| Hartley, TF | 1 |
| Seale, JP | 1 |
| Compton, MR | 1 |
| Eberl, S | 2 |
| Gervaziev, DV | 1 |
| Chuchalin, AG | 1 |
| Oganov, VS | 1 |
| Shmushkovich, BI | 1 |
| Dubonos, SL | 1 |
| Sjödén, G | 1 |
| Kessler, D | 1 |
| Meister, W | 1 |
| Yamazaki, I | 1 |
| Shino, A | 1 |
| Shimizu, Y | 1 |
| Tsukuda, R | 1 |
| Shirakawa, Y | 1 |
| Kinoshita, M | 1 |
| Nicoll, JJ | 1 |
| Brown, N | 1 |
| Kaiser, H | 1 |
| Biró, I | 1 |
| Larsson, SE | 4 |
| Vejlens, L | 2 |
| Strohmeyer, G | 1 |
| Spuck, W | 1 |
| Martini, GA | 1 |
| Pooler, HE | 1 |
| Gifford, RH | 1 |
| Carré, M | 1 |
| Ayigbedé, O | 1 |
| Miravet, L | 1 |
| Rasmussen, H | 1 |
| Gallagher, JC | 1 |
| Aaron, J | 1 |
| Horsman, A | 1 |
| Wilkinson, R | 1 |
| Gönczi, J | 1 |
| Szemere, P | 1 |
| Bódi, S | 1 |
| Boga, M | 1 |
| Muschter, K | 1 |
| Scholz, O | 1 |
| Khudoleeva, AB | 1 |
| Schoger, GA | 1 |
| Sevastikoglou, JA | 1 |
| Kenny, FM | 1 |
| Seidel, A | 1 |
| Schuster, J | 1 |
| Meier-Ruge, W | 1 |
| Egli, F | 1 |
| Volk, H | 1 |
| Raab, W | 1 |
| Illig, H | 1 |
| Frank, O | 1 |
| Klemmayer, K | 1 |
| Möller, E | 1 |
| Brinkmann, W | 1 |
| Weber, O | 1 |
| Wildhirt, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis: a Randomized Controlled Trial[NCT01465568] | Phase 4 | 40 participants (Actual) | Interventional | 2011-12-31 | Completed | ||
| Efficacy of Denosumab and Zoledronic Acid in the Treatment of Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density: a Prospective Controlled Trial[NCT04034199] | Phase 3 | 40 participants (Anticipated) | Interventional | 2019-08-15 | Not yet recruiting | ||
| Short Term Study on the Effect of a Fixed Dose of 12.5 mg of Prednisone as Starting Dose in Polymyalgia Rheumatica[NCT01169597] | Phase 4 | 60 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794] | Phase 3 | 94 participants (Anticipated) | Interventional | 2019-03-01 | Recruiting | ||
| Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus-Prevalence,Risk Factors and Treatment[NCT00668330] | Phase 4 | 40 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| "Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD - a Randomized, Double-blind, Non-inferiority Study (The RECUT-Trial)"[NCT02386735] | 470 participants (Anticipated) | Interventional | 2015-03-31 | Recruiting | |||
| A Prospective Baseline Assessment of the Risk of Osteoporosis in Patients With Chronic Obstructive Lung Disease and Outcomes After 2 Years; a Pilot Study[NCT01161680] | 30 participants (Actual) | Observational | 2010-07-31 | Completed | |||
| ACtive Care After Transplantation, a Lifestyle Intervention in Renal Transplant Recipients[NCT01047410] | 221 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
29 reviews available for prednisolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Humans; Osteo | 2023 |
[Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Comorbidity; Glucocorticoids; Humans; Osteoporosis; Prednisolone | 2021 |
[Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
Topics: Bone Density Conservation Agents; Diphosphonates; Evidence-Based Medicine; Fractures, Spontaneous; G | 2014 |
[Therapy and prognosis of medium and small vessel vasculitis].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Cyclophosphamide; Drug Therapy, Combinat | 2014 |
Safety of low- to medium-dose glucocorticoid treatment in rheumatoid arthritis: myths and reality over the years.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone Density; Glucocorticoids; Humans; Observational St | 2014 |
[Glucocorticoid and bone].
Topics: Administration, Ophthalmic; Adult; Aged; Alendronate; Animals; Bone Density; Bone Density Conservati | 2014 |
[An update on glucocorticoid-induced osteoporosis].
Topics: Administration, Oral; Bone Density; Calcium, Dietary; Cholecalciferol; Dose-Response Relationship, D | 2016 |
Risk-benefit assessment in management of adult idiopathic thrombocytopenic purpura.
Topics: Adrenal Cortex Hormones; Animals; Arteriosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Huma | 2011 |
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.
Topics: Aged; Bone Density; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Fractures, Bo | 2002 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; An | 2003 |
[Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
Topics: Aged; Alendronate; Anti-Inflammatory Agents; Bone Density; Cholecalciferol; Drug Therapy, Combinatio | 2004 |
[Glucocorticoid-induced osteoporosis and bone mineral densimetry].
Topics: Absorptiometry, Photon; Adult; Bone and Bones; Bone Density; Diphosphonates; Fractures, Bone; Glucoc | 2004 |
[Corticosteroids for treatment of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Drug Resistance; Femur Head Necrosis; Glucocorticoids; Humans; Methylpredniso | 2005 |
[Adverse effects of corticosteroids in treatment of rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Arthritis, Rheumatoid; Communicable Diseases; Fractu | 2005 |
[Management of glucocorticoid-induced osteoporosis].
Topics: Bone and Bones; Bone Density; Cholecalciferol; Diphosphonates; Fractures, Bone; Glucocorticoids; Hum | 2005 |
[Medical prophylaxis and treatment of steroid induced osteoporosis].
Topics: Bone Density; Calcitonin; Calcium; Diphosphonates; Drug Therapy, Combination; Evidence-Based Medicin | 2005 |
[Osteoporosis caused by pediatric diseases].
Topics: Anorexia Nervosa; Bone Density; Calcium; Child; Diphosphonates; Gonadotropin-Releasing Hormone; Huma | 2005 |
Polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Polymy | 2006 |
[Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Topics: Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Evidence-Based Medi | 2006 |
[Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
Topics: Apoptosis; Bone and Bones; Bone Density; Bone Resorption; Fractures, Spontaneous; Glucocorticoids; H | 2008 |
[Osteoporosis in collagen diseases].
Topics: Arthritis, Rheumatoid; Bone and Bones; Fractures, Stress; Humans; Osteoporosis; Prednisolone | 1994 |
Low dose corticosteroids in early rheumatoid arthritis. Can these drugs slow disease progression?
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Disease Progression; Glucocorticoids; Humans; Multi | 1996 |
A case of primary hyperparathyroidism accompanying multiple myeloma.
Topics: Aged; Antineoplastic Agents; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Low Ba | 1997 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Co | 2001 |
[Use of glucocorticoids in rheumatoid arthritis. Inhibition of disease progression versus risk of steroid osteoporosis].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Disease Progression; Dose-Response Relationship, Dr | 2001 |
[Systemic complications in patients with rheumatism and collagen disease and their treatment].
Topics: Amyloidosis; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Collagen Diseases; | 2002 |
Side-effects of corticosteroid agents.
Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Adult; Aged; Child; Eye Diseases; Female; Femur Hea | 1986 |
Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
Topics: Animals; Biological Transport; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Diso | 1985 |
Corticosteroid therapy for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Rheumatoid; Atrophy; Betamethasone; | 1973 |
42 trials available for prednisolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Topics: Biopsy; Denmark; Fluorodeoxyglucose F18; Giant Cell Arteritis; Humans; Middle Aged; Neoplasms; Osteo | 2017 |
The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; Denosumab; | 2018 |
The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial.
Topics: Adult; Blood Glucose; Dose-Response Relationship, Drug; Double-Blind Method; Glucocorticoids; Humans | 2018 |
Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling | 2015 |
Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling | 2015 |
Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling | 2015 |
Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
Topics: Absorptiometry, Photon; Adult; Aged; Bone Density; Bone Density Conservation Agents; Bone Remodeling | 2015 |
Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy.
Topics: Adolescent; Adult; Alendronate; Autoimmune Diseases; Bone Density; Bone Density Conservation Agents; | 2008 |
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Drug Administration S | 2010 |
Alendronate improves low bone mineral density induced by steroid therapy in Crohn's disease.
Topics: Absorptiometry, Photon; Adult; Alendronate; Alkaline Phosphatase; Bone Density; Bone Density Conserv | 2009 |
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study.
Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Resorptio | 2010 |
Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome.
Topics: Adult; Bone Density; Bone Density Conservation Agents; Etidronic Acid; Female; Humans; Hydroxycholec | 2010 |
Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Diphosphonates; Doubl | 2010 |
Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Topics: Absorptiometry, Photon; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Bone Density; | 2012 |
Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Alendronate; Anti-Inflammatory Agents; Autoimmune Diseases; Bone Densit | 2012 |
The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients.
Topics: Adult; Aged; Body Composition; Bone Density; Female; Femur Neck; Glucocorticoids; Humans; Immunosupp | 2003 |
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn's disease.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Bone Density; Budesonide; Crohn Disease; Do | 2005 |
A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids.
Topics: Adult; Aged; Bone Density; Calcium; Cholecalciferol; Female; Graft Rejection; Humans; Kidney Transpl | 2005 |
Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Topics: Adolescent; Adult; Biomarkers; Bone Density; Bone Remodeling; Child; Cross-Sectional Studies; Dose-R | 2005 |
Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Topics: Anti-Inflammatory Agents; Bone Density; Budesonide; Crohn Disease; Delayed-Action Preparations; Doub | 2005 |
Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.
Topics: Bone Density; Bone Density Conservation Agents; Calcium; Child, Preschool; Dietary Supplements; Fema | 2006 |
Risedronate for prevention of bone mineral density loss in patients receiving high-dose glucocorticoids: a randomized double-blind placebo-controlled trial.
Topics: Adipose Tissue; Adult; Aged; Anti-Inflammatory Agents; Body Mass Index; Bone Density; Bone Density C | 2008 |
Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
Topics: Aged; Alkaline Phosphatase; Arthritis, Rheumatoid; Bone Density; Bone Density Conservation Agents; C | 2008 |
Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy.
Topics: Adult; Aged; Bone and Bones; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Osteoporos | 1984 |
Increased bone density in patients on steroids with etidronate.
Topics: Aged; Bone Density; Etidronic Acid; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisolone | 1994 |
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications.
Topics: Adult; Aged; Analgesia; Bone Diseases; Bone Resorption; Calcium; Clodronic Acid; Female; Fractures, | 1993 |
Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial.
Topics: Absorptiometry, Photon; Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Bone Density; Calcium; Di | 1997 |
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.
Topics: Aged; Alkaline Phosphatase; Androstenedione; Anti-Inflammatory Agents; Bone and Bones; Bone Density; | 1998 |
Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients.
Topics: Absorptiometry, Photon; Administration, Inhalation; Administration, Oral; Analgesics, Non-Narcotic; | 1998 |
A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
Topics: Aged; Asthma; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Etidronic Acid; | 1998 |
Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Calc | 1999 |
Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
Topics: Alendronate; Bone Density; Etidronic Acid; Female; Fractures, Bone; Glucocorticoids; Humans; Osteopo | 1999 |
Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis.
Topics: Absorptiometry, Photon; Adolescent; Adult; Anti-Inflammatory Agents; Bone Density; Calcium; Chronic | 2000 |
Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Biomarkers; Bone and Bones; Bone Density; | 2000 |
Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Bone Density; Calcium Channel Blockers; Double-Bl | 2000 |
Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Topics: Alkaline Phosphatase; Bone Density; Bone Remodeling; Calcium; Collagen; Collagen Type I; Diphosphona | 2001 |
Osteoporosis with low dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry.
Topics: Absorptiometry, Photon; Bone Density; Female; Fractures, Spontaneous; Glucocorticoids; Humans; Male; | 2001 |
Osteoporosis after organ transplantation.
Topics: Absorptiometry, Photon; Belgium; Bone Density; Dose-Response Relationship, Drug; Drug Therapy, Combi | 2001 |
Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol.
Topics: Adolescent; Bone Density; Child; Child, Preschool; Female; Glucocorticoids; Humans; Hydroxycholecalc | 2001 |
The assessment of the systemic effects of inhaled glucocorticosteroids. The effects of inhaled budesonide vs oral prednisolone on calcium metabolism.
Topics: Administration, Inhalation; Adult; Aerosols; Budesonide; Calcium; Double-Blind Method; Glucocorticoi | 1991 |
[Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis].
Topics: Adult; Bone Density; Calcium; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; | 1989 |
[Disorders of calcium and bone metabolism in glucocorticoid treatment].
Topics: Adolescent; Adrenocorticotropic Hormone; Bone Resorption; Calcium; Child; Child, Preschool; Dexameth | 1988 |
Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow Cells; Bone Marrow Examination; Child; Child, Presch | 1969 |
[On the evaluation of the effect of a combination of salicylates and prednisolone in rheumatic diseases].
Topics: Acute Disease; Arthritis, Rheumatoid; Bone Diseases; Clinical Trials as Topic; Drug Synergism; Human | 1968 |
[Betamethasone in the asthmatic syndrome].
Topics: Adult; Aged; Asthma; Betamethasone; Female; Humans; Lung; Male; Middle Aged; Osteoporosis; Pituitary | 1967 |
206 other studies available for prednisolone and Age-Related Osteoporosis
| Article | Year |
|---|---|
Integration of Zebrafish Model and Network Pharmacology to Explore Possible Action Mechanisms of Morinda officinalis for Treating Osteoporosis.
Topics: Animals; Cell Differentiation; China; Disease Models, Animal; Drugs, Chinese Herbal; Medicine, Chine | 2020 |
Network pharmacology approach to elucidate possible action mechanisms of Sinomenii Caulis for treating osteoporosis.
Topics: Animals; Anti-Inflammatory Agents; Bone and Bones; Bone Density Conservation Agents; Bone Remodeling | 2020 |
Glucocorticoid-Induced Osteoporosis Prevention in Polymyalgia Rheumatica Patients.
Topics: Absorptiometry, Photon; Aged; Bone Density Conservation Agents; Diphosphonates; Female; Glucocortico | 2020 |
Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Line; Cell Survival; Disease Models, Animal; Esterase | 2021 |
Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Calcium Carbonate; Deno | 2017 |
Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Denosumab; Female; Glucocorticoids; Humans; Imm | 2017 |
WNT16 overexpression partly protects against glucocorticoid-induced bone loss.
Topics: Animals; Bone Density; Bone Diseases, Metabolic; Cytoprotection; Female; Glucocorticoids; Mice; Mice | 2018 |
Possible mechanisms of prednisolone-induced osteoporosis in zebrafish larva.
Topics: Animals; Extracellular Matrix; Gene Expression Regulation; Larva; Osteoblasts; Osteoporosis; Phenoty | 2018 |
Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital.
Topics: Adult; Aged; Bone Density Conservation Agents; Diphosphonates; Drug Monitoring; Drug Prescriptions; | 2018 |
Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
Topics: Adult; Biomarkers; Bone Density; Bone Density Conservation Agents; Drug Administration Schedule; Fem | 2018 |
Transcriptome analysis reveals functional roles of nacreous protein N16 in prednisolone-induced osteoporotic zebrafish.
Topics: Animals; Bone Density; Extracellular Matrix Proteins; Gene Expression Profiling; Molecular Sequence | 2019 |
Fangchinoline Promotes Autophagy and Inhibits Apoptosis in Osteoporotic Rats.
Topics: Animals; Apoptosis; Autophagy; Benzylisoquinolines; Bone Density; Bone Resorption; China; Disease Mo | 2019 |
Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway.
Topics: 4-Butyrolactone; Angelica sinensis; Animals; Apoptosis; Bone Density Conservation Agents; Cell Line; | 2019 |
Effective treatment of a steroid-induced femoral neck fracture nonunion with a once-weekly administration of teriparatide in a rheumatoid patient: a case report.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone Density Conservation Agents | 2013 |
Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cohort Studies; Female; General Practice; Humans; | 2013 |
Bone protection in chronic obstructive pulmonary disease (COPD) patients requiring regular intermittent glucocorticoid therapy.
Topics: Aged; Bone Density Conservation Agents; Glucocorticoids; Humans; Osteoporosis; Prednisolone; Pulmona | 2013 |
Prednisolone induces osteoporosis-like phenotype in regenerating zebrafish scales.
Topics: Animal Structures; Animals; Bone Density; Disease Models, Animal; Gene Expression Profiling; Gene Ex | 2014 |
Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Mass Index; Bone Den | 2014 |
Role of Triticum aestivum aqueous extract in glucocorticoid induced osteoporosis in rats.
Topics: Animals; Bone Density; Bone Resorption; Collagen; Etidronic Acid; Femur; Free Radical Scavengers; Gl | 2014 |
Bone safety of low-dose glucocorticoids in rheumatic diseases.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Bone Density Conservation | 2014 |
[Screening on antiosteoporotic active parts of dipsacus radix based on zebrafish model].
Topics: Animals; Bone Density Conservation Agents; Chromatography, High Pressure Liquid; Dipsacaceae; Diseas | 2014 |
Quantitative computed tomographic assessment of bone mineral density changes associated with administration of prednisolone or prednisolone and alendronate sodium in dogs.
Topics: Administration, Oral; Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Dog Dise | 2015 |
Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.
Topics: Acid Phosphatase; Alendronate; Alkaline Phosphatase; Animals; Biomarkers; Bone Density Conservation | 2015 |
Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.
Topics: Adult; Age Distribution; Aged; Cohort Studies; Comorbidity; Databases, Factual; Female; Glucocortico | 2015 |
Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation.
Topics: Adult; Biomarkers; Bone Density; Female; Femur Neck; Humans; Kidney Transplantation; Logistic Models | 2016 |
Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long-term glucocorticoids.
Topics: Bone Density Conservation Agents; Dermatology; Female; Glucocorticoids; Humans; Male; Middle Aged; O | 2015 |
Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.
Topics: Adult; Female; Glucocorticoids; Graft Rejection; Hepatitis, Autoimmune; Humans; Immunosuppressive Ag | 2016 |
Immunolocalization of MMP 2, 9 and 13 in prednisolone induced osteoporosis in mice.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glucocorticoids; Immunohistochemistry; Ma | 2016 |
BONE MINERAL DENSITY IN PATIENTS WITH ADDISON DISEASE ON REPLACEMENT THERAPY WITH PREDNISOLONE.
Topics: Absorptiometry, Photon; Addison Disease; Adult; Aged; Bone Density; Case-Control Studies; Cross-Sect | 2016 |
Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone and Bones; Endocannabinoids; Gene Expression R | 2016 |
IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse.
Topics: Animals; Antibodies, Neutralizing; beta Catenin; Disease Models, Animal; Glucocorticoids; Interleuki | 2016 |
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Topics: Absorptiometry, Photon; Adrenal Hyperplasia, Congenital; Adult; Bone Density; Dexamethasone; Female; | 2016 |
Fracture in Duchenne Muscular Dystrophy: Natural History and Vitamin D Deficiency.
Topics: Adolescent; Adrenal Cortex Hormones; Australia; Body Mass Index; Bone Density; Child; Dietary Supple | 2016 |
An intergated serum and urinary metabonomic research based on UPLC-MS and therapeutic effects of Gushudan on prednisolone-induced osteoporosis rats.
Topics: Animals; Biomarkers; Drugs, Chinese Herbal; Male; Metabolic Networks and Pathways; Metabolome; Metab | 2016 |
Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice.
Topics: Animals; Bone Density; Bone Remodeling; Disease Models, Animal; Female; Femur; Glucocorticoids; Mice | 2016 |
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Comorbidity; Diabetes Mellitus; Female; Follow-Up Stu | 2017 |
Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.
Topics: Animals; Bone Density; Bone Remodeling; Cell Differentiation; Cells, Cultured; Disease Models, Anima | 2017 |
A case of multiple vertebral compression fractures due to glucocorticoid-induced osteoporosis in a pediatric patient with nephrotic syndrome
.
Topics: Bone Density; Child; Drug Administration Schedule; Fractures, Compression; Glucocorticoids; Humans; | 2017 |
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Diabetes Mellitus; Dose-Response Relationship, Drug; | 2017 |
Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry.
Topics: Animals; Bone Density; Bone Remodeling; Bone Resorption; Disease Models, Animal; Dose-Response Relat | 2008 |
Influence of prednisolone-induced osteoporosis on bone mass and bone quality of the mandible in rats.
Topics: Animals; Biomechanical Phenomena; Bone Density; Femur; Glucocorticoids; Male; Mandible; Osteoporosis | 2009 |
Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.
Topics: Adolescent; Adult; Aged; Asian People; Black People; Female; Follow-Up Studies; Glucocorticoids; Hum | 2009 |
Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL.
Topics: Acid Phosphatase; Amino Acids; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B | 2009 |
Efficacy of tacrolimus against Churg-Strauss syndrome in a patient with myasthenia gravis.
Topics: Aged; Asthma; Blood Vessels; Churg-Strauss Syndrome; Comorbidity; Eosinophilia; Female; Humans; Immu | 2010 |
Multimodal therapy for vertebral involvement of systemic mastocytosis.
Topics: Adult; Back Pain; Biomarkers; Biopsy; Bone Density; Bone Density Conservation Agents; Diphosphonates | 2009 |
Osteoporosis and related risk factors in renal transplant recipients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Bone Diseases, Metabolic; Creatinine; Cyclo | 2009 |
BSR and BHPR guidelines for the management of polymyalgia rheumatica.
Topics: Aged; Diagnosis, Differential; Drug Administration Schedule; Glucocorticoids; Humans; Middle Aged; O | 2010 |
BSR and BHPR guidelines for the management of polymyalgia rheumatica.
Topics: Aged; Diagnosis, Differential; Drug Administration Schedule; Glucocorticoids; Humans; Middle Aged; O | 2010 |
BSR and BHPR guidelines for the management of polymyalgia rheumatica.
Topics: Aged; Diagnosis, Differential; Drug Administration Schedule; Glucocorticoids; Humans; Middle Aged; O | 2010 |
BSR and BHPR guidelines for the management of polymyalgia rheumatica.
Topics: Aged; Diagnosis, Differential; Drug Administration Schedule; Glucocorticoids; Humans; Middle Aged; O | 2010 |
[Experimental steroid osteoporosis in rats and the way to restore the bone tissue structure].
Topics: Animals; Bone Regeneration; Bone Transplantation; Disease Models, Animal; Femur; Male; Osteoporosis; | 2010 |
Recurrent fractures in an elderly patient with systemic lupus erythematosus.
Topics: Aged; Bone Density; Female; Fractures, Bone; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; | 2009 |
Belinda's back pain.
Topics: Absorptiometry, Photon; Adult; Back Pain; Bone Density; Bone Density Conservation Agents; Diphosphon | 2010 |
Effects of a vitamin D analog, alfacalcidol, on bone and skeletal muscle in glucocorticoid-treated rats.
Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Female; Glucocorticoids; Hy | 2010 |
Role of dehydroepiandrosterone in management of glucocorticoid-induced secondary osteoporosis in female rats.
Topics: Animals; Bone and Bones; Dehydroepiandrosterone; Female; Glucocorticoids; Osteoporosis; Prednisolone | 2012 |
Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen; Cros | 2011 |
[Diagnosis and treatment of osteoporosis in nonmetastatic breast cancer].
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; G | 2011 |
Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.
Topics: Anatomy, Cross-Sectional; Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Etid | 2011 |
Association of osteonecrosis and osteoporosis in HIV-1-infected patients.
Topics: Absorptiometry, Photon; Adenine; Alcohol Drinking; Anti-HIV Agents; California; Female; HIV Infectio | 2011 |
Raman spectroscopy detects deterioration in biomechanical properties of bone in a glucocorticoid-treated mouse model of rheumatoid arthritis.
Topics: Analysis of Variance; Animals; Arthritis, Rheumatoid; Biomechanical Phenomena; Disease Models, Anima | 2011 |
Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats.
Topics: Adrenergic beta-Antagonists; Animals; Bone and Bones; Bone Density; Glucocorticoids; Male; Osteoporo | 2011 |
Metabonomic study on the anti-osteoporosis effect of Rhizoma Drynariae and its action mechanism using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Alkaline Phosphatase; Animals; Biomarkers; Bone Density; Bone Density Conservation Agents; Chromatog | 2012 |
Practice Gaps. Improving the care of our patients who are receiving glucocorticoid therapy.
Topics: Alendronate; Anti-Inflammatory Agents; Autoimmune Diseases; Bone Density Conservation Agents; Female | 2012 |
Effects of thalidomide on the development of bone damage caused by prednisolone in rats.
Topics: Administration, Oral; Animals; Bone Remodeling; Dose-Response Relationship, Drug; Femur; Glucocortic | 2012 |
Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT.
Topics: Absorptiometry, Photon; Adult; Biomechanical Phenomena; Bone Density; Bone Diseases, Metabolic; Case | 2013 |
Potential role of leptin against glucocorticoid-induced secondary osteoporosis in adult female rats.
Topics: Animals; Bone Density; Female; Leptin; Osteoporosis; Osteoprotegerin; Prednisolone; RANK Ligand; Rat | 2012 |
[Diagnosing and treating osteoporosis in patients with chronic obstructive pulmonary disease].
Topics: Absorptiometry, Photon; Algorithms; Critical Pathways; Fractures, Bone; Glucocorticoids; Humans; Ost | 2012 |
The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis.
Topics: Animals; Apoptosis; Blotting, Western; Body Composition; Cartilage, Articular; Caspase 3; Glucocorti | 2013 |
Osteoporosis with underlying connective tissue disease: an unusual case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Accidental Falls; Adult; Anti-Ulcer Agents; Antibodies, Ant | 2002 |
Vertebral fracture and cortical bone changes in corticosteroid-induced osteoporosis.
Topics: Administration, Oral; Aged; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bone and Bones; Bone Dens | 2002 |
Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease?
Topics: Absorptiometry, Photon; Adult; Aged; Body Mass Index; Bone Density; Crohn Disease; Female; Femur; Gl | 2002 |
Corticosteroid-induced osteoporosis in patients with uveitis.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Bone Density; Drug Administration Schedule; Female | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
The impact of oral corticosteroid use on bone mineral density and vertebral fracture.
Topics: Administration, Inhalation; Administration, Oral; Age Distribution; Aged; Aged, 80 and over; Bone De | 2002 |
Steroids cause osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Male; Med | 2002 |
[The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Bone Density; Collagen Dise | 2002 |
[The patient suffers from rheumatism for many years. It also makes the bones brittle].
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Diphosphonates; Female; Glucocorticoids; Humans; Ma | 2002 |
[The usefulness of the quantitative ultrasound to diagnose glucocorticoids induced osteoporosis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Calcaneus; Female; Glucocort | 2002 |
Evolution of bone stiffness in renal transplant patients measured by quantitative ultrasound.
Topics: Bone Density; Calcium; Glucocorticoids; Humans; Kidney Failure, Chronic; Kidney Transplantation; Mid | 2003 |
Relationship between glucocorticoid-induced osteoporosis and vitamin D receptor genotypes.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Bone Density; Female; Genotype; Humans; Lupus Erythematosu | 2002 |
Lower serum beta-CrossLaps in male cardiac transplant recipients treated without prednisolone.
Topics: Bone Density; Bone Diseases, Metabolic; Collagen; Cross-Sectional Studies; Cyclosporine; Drug Therap | 2003 |
[Bone mineral density in idiopathic inflammatory myopathies].
Topics: Absorptiometry, Photon; Adult; Aged; Anti-Inflammatory Agents; Bone Density; Case-Control Studies; D | 2003 |
Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis.
Topics: Absorptiometry, Photon; Arthritis, Juvenile; Bone Density; Calcium; Child; Diet; Female; Glucocortic | 2003 |
Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids.
Topics: Absorptiometry, Photon; Aged; Anti-Inflammatory Agents; Bone Density; Calcitriol; Case-Control Studi | 2003 |
Corticosteroid-induced osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Male; Medical Audit; Middle Aged; O | 2003 |
[Treatment of Sudeck's syndrome in diabetes mellitus with prednisolone; case report].
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Osteoporosis; Prednisolone | 1958 |
[Treatment of pelvic arthropathy of pregnancy with dexamethasone].
Topics: Dexamethasone; Disease; Female; Humans; Joint Diseases; Joints; Osteoporosis; Pelvis; Prednisolone; | 1960 |
[Clinical observations of low back pain over 7 years].
Topics: Back Pain; Chondroitin; Glucuronates; Humans; Low Back Pain; Osteoarthritis; Osteoporosis; Prednisol | 1963 |
TREATMENT OF OSTEOPOROSIS WITH AN ANABOLIC COMPOUND AND L-LYSINE.
Topics: Amino Acids; Anabolic Agents; Appetite; Arthritis; Arthritis, Rheumatoid; Dietary Proteins; Emotions | 1963 |
[ATTEMPTED EVALUATION OF THE OSSEOUS HAZARD IN ASTHMATICS SUBJECTED TO LONG-TERM CORTICOID TREATMENT].
Topics: Adrenal Cortex Hormones; Asthma; Bone and Bones; Cortisone; Dexamethasone; Hydrocortisone; Methylpre | 1963 |
[CALCIUM THERAPY OF OSTEOPOROSIS. DETERMINATION OF BONE DENSITY AS A CRITERION].
Topics: Aging; Anabolic Agents; Arthritis; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Calcium; Ger | 1963 |
[CONGENITAL HYPOPLASTIC STATE OF THE HEMATOPOIETIC SYSTEM IN CHILDREN].
Topics: Anemia; Anemia, Aplastic; Ascorbic Acid; Bilirubin; Blood Cell Count; Blood Chemical Analysis; Blood | 1963 |
SIDE-EFFECTS OF LONG-TERM TREATMENT WITH CORTICOSTEROIDS AND CORTICOTROPHIN.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis; Arthritis, Rheumatoid; Contusions; | 1964 |
[SPONTANEOUS FRACTURES OF THE FEMORAL NECK DURING CORTICOID THERAPY].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Femoral Neck Fractures; Femur Neck; Fractures, | 1964 |
[COMPLICATIONS FOLLOWING PREDNISOLONE THERAPY OF ALLERGIC PAPULO-NECROTIC VASCULITIS].
Topics: Dermatitis; Gangrene; Humans; Necrosis; Osteoporosis; Pathology; Prednisolone; Purpura; Pyoderma; St | 1964 |
Glucocorticoids in palliative medicine: is osteoporosis a problem?
Topics: Adult; Aged; Aged, 80 and over; Dexamethasone; Glucocorticoids; Humans; Middle Aged; Osteoporosis; P | 2003 |
[How can corticosteroid-induced osteoporosis be prevented and treated?].
Topics: Glucocorticoids; Humans; Osteoporosis; Prednisolone | 2003 |
The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model.
Topics: Adipocytes; Animals; Blotting, Western; Bone Density; Cyclooxygenase 2; Disease Models, Animal; Enzy | 2003 |
The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
Topics: Animals; Apoptosis; Body Weight; Bone and Bones; Bone Density; Cell Division; Compressive Strength; | 2004 |
Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients.
Topics: Adult; Aged; Aged, 80 and over; Bone Density; Cross-Sectional Studies; Diphosphonates; Female; Gluco | 2004 |
Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Chemoprevention; Diphosphonates; Education, Continuing; Fem | 2004 |
Bone density in myasthenia gravis patients receiving long-term prednisolone therapy.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Autoantibodies; Bone Density; Cross-Sectiona | 2004 |
Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Topics: Adrenal Cortex Hormones; Adult; Female; Humans; Immunosuppressive Agents; Myasthenia Gravis; Osteopo | 2004 |
Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment.
Topics: Arthritis, Rheumatoid; Case-Control Studies; Etidronic Acid; Female; Humans; Kynurenine; Methotrexat | 2003 |
Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density Conservation Agents; Dose-Response Relationship, | 2004 |
Prevalence and predictors of fragility fractures in systemic lupus erythematosus.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bone Density; Cross-Sectional Studies; Engl | 2005 |
Rufo v Hosking [2004] NSWCA 391.
Topics: Dexamethasone; Humans; Lupus Erythematosus, Systemic; Malpractice; New South Wales; Osteoporosis; Pr | 2005 |
Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
Topics: Absorptiometry, Photon; Adjuvants, Immunologic; Alendronate; Animals; Body Weight; Bone and Bones; B | 2005 |
[Practical ambulatory therapy for multisystem atrophy and diabetes mellitus].
Topics: Aged; Ambulatory Care; Anti-Inflammatory Agents; Calcium; Diabetes Mellitus, Type 2; Female; Humans; | 2005 |
[Risedronate: a possible treatment for extraosseous calcification].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; CREST Syndrome; Etidronic | 2005 |
[Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relations | 2005 |
Loss of chance: what loss?
Topics: Adolescent; Allergy and Immunology; Dexamethasone; Family Practice; Female; Glucocorticoids; Humans; | 2006 |
Effects of Chinese herbal medicine based on hachimi-jio-gan on osteopenia in rats.
Topics: Animals; Drugs, Chinese Herbal; Female; Osteoporosis; Ovariectomy; Phytotherapy; Prednisolone; Rats; | 2006 |
Severe osteoporosis and multiple fractures in an AIDS patient treated with short-term steroids for lymphoma: a need for guidelines.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Burkitt Lymphoma; Fractures, Comp | 2006 |
Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005.
Topics: Adrenal Cortex Hormones; Aged; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonate | 2007 |
Physician's awareness of the prevention of corticosteroid induced osteoporosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium; Clinical Competence; Glucocorticoids; Humans; M | 2007 |
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.
Topics: Adolescent; Adult; Biomarkers; Bone and Bones; Bone Density; Bone Resorption; Calcium; Child; Child, | 2007 |
Systemic lupus erythematosus (SLE) and aseptic bone necrosis. A discussion based on the presentation of one case treated with corticosteroids.
Topics: Female; Femur Head; Hip Joint; Humans; Lupus Erythematosus, Systemic; Necrosis; Osteoporosis; Predni | 1967 |
Studies on osteoporoses. VIII. Effect of estrogen on steroid induced osteoporosis.
Topics: Adrenal Cortex Hormones; Aging; Animals; Calcium; Estrogens; Estrogens, Conjugated (USP); Female; Mi | 1982 |
Effects of 1,25(OH)2D3 on bone tissue in the rabbit: studies on fracture healing, disuse osteoporosis, and prednisone osteoporosis.
Topics: Animals; Calcitriol; Dose-Response Relationship, Drug; Fractures, Closed; Immobilization; Male; Oste | 1984 |
Corticosteroids causing severe growth suppression in juvenile rheumatoid arthritis.
Topics: Arthritis, Juvenile; Child; Child, Preschool; Growth Disorders; Humans; Male; Osteoporosis; Predniso | 1984 |
Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone and Bones; Female; Humans; Male; Menopause; Middle Aged; Osteoporosis; P | 1984 |
IgG therapy in systemic lupus erythematosus--two case reports.
Topics: Azathioprine; Child; Cushing Syndrome; Female; Humans; Immunoglobulin G; Lupus Erythematosus, System | 1984 |
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Composition; Calcium; Dose-Respon | 1982 |
Acute collapse of thoracic vertebral bodies after long-term steroid treatment in leprosy.
Topics: Adult; Female; Humans; Leprosy; Osteoporosis; Prednisolone; Radiography; Thoracic Vertebrae; Time Fa | 1982 |
Studies on osteoporosis. IX. Effect of fluoride on steroid induced osteoporosis.
Topics: Adrenal Cortex Hormones; Animals; Bone and Bones; Calcium; Female; Fluorides; Mice; Mice, Inbred C3H | 1982 |
[Various complications of hormone therapy of children with rheumatoid arthritis].
Topics: Arthritis, Juvenile; Child; Femur Head Necrosis; Humans; Male; Osteoporosis; Prednisolone | 1981 |
The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.
Topics: Adult; Aged; Blood Proteins; Calcitonin; Female; Humans; Male; Middle Aged; Osteoporosis; Parathyroi | 1994 |
Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Adult; Azathioprine; Cyclosporine; Dose-Response Relati | 1993 |
Serum tartrate-resistant acid phosphatase (TRAP) as a biochemical marker of bone remodeling.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Calcitonin; Cytarabine; | 1993 |
Osteoporosis in steroid-dependent asthma.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Asthma; Bone Density; Humans; Lumbosacral Re | 1996 |
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Arthritis | 1996 |
Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections.
Topics: Absorptiometry, Photon; Adult; Bone Density; Case-Control Studies; Colon; Crohn Disease; Female; Fem | 1997 |
Prevention of glucocorticoid induced osteoporosis.
Topics: Bone Density; Calcium; Fractures, Spontaneous; Glucocorticoids; Humans; Osteoporosis; Prednisolone; | 1997 |
Prevention of corticosteroid-induced bone loss with alendronate.
Topics: Adrenal Cortex Hormones; Alendronate; Animals; Bone Density; Estradiol; Estrogens; Female; Femur; Ma | 1998 |
[Case of intractable ulcerative colitis resistant to steroid high-dose venous-infusion therapy treated by leukocytapheresis].
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Drug Resistance; Female; Humans; Infusions, In | 1997 |
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Topics: Adult; Animals; Apoptosis; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Cells, | 1998 |
Management of bone disease in patients on long term glucocorticoid therapy.
Topics: Bone Density; Calcium; Diphosphonates; Drug Administration Schedule; Glucocorticoids; Hormone Replac | 1999 |
Severe complications of ulcerative colitis after high-dose prednisolone and azathioprine treatment.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Colonoscopy; Dose-Response Relat | 1999 |
A young man with bronchial asthma and an abnormal chest X-ray.
Topics: Adult; Anti-Inflammatory Agents; Asthma; Cushing Syndrome; Humans; Male; Osteoporosis; Prednisolone; | 2000 |
[Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
Topics: Adult; Asthma; Calcifediol; Calcium; Calcium Carbonate; Cholecalciferol; Drug Combinations; Female; | 1999 |
Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Bone and Bones; Bone Density; Calcifediol; Calcitriol; | 2000 |
A case report of insufficiency fracture of the Fossa acetabuli in a patient with rheumatoid arthritis.
Topics: Acetabulum; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; F | 2000 |
[Osteoporotic fracture of the vertebral body in patients with steroid dependent bronchial asthma].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Asthma; Female; H | 2000 |
Bone mineral density in the long term after liver transplantation.
Topics: Absorptiometry, Photon; Adolescent; Adult; Anti-Inflammatory Agents; Antimetabolites; Azathioprine; | 2000 |
Myasthenia gravis, corticosteroids and osteoporosis prophylaxis.
Topics: Adrenal Cortex Hormones; Guideline Adherence; Humans; Myasthenia Gravis; Osteoporosis; Prednisolone; | 2001 |
Osteoporosis after renal transplantation: single center experience.
Topics: Adult; Bone Density; Cyclosporine; Dose-Response Relationship, Drug; Female; Femur Neck; Glucocortic | 2001 |
Osteoporosis in primary biliary cirrhosis revisited.
Topics: Absorptiometry, Photon; Aged; Anti-Inflammatory Agents; Bone Density; Calcium; Cohort Studies; Estro | 2001 |
[Risk of osteoporosis in steroid therapy. When and how to counter the risk].
Topics: Anti-Inflammatory Agents; Bone Density; Dose-Response Relationship, Drug; Female; Fractures, Spontan | 2001 |
Osteoporosis and fracture risk prevention in long-term glucocorticoid therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Calcium; Child; Estrogen Repla | 2001 |
Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients : a 4-year longitudinal study.
Topics: Absorptiometry, Photon; Administration, Inhalation; Administration, Oral; Anti-Asthmatic Agents; Ast | 2001 |
The role of cytokines in the changes in bone turnover following bone marrow transplantation.
Topics: Adult; Biomarkers; Bone Marrow Transplantation; Bone Remodeling; Cytokines; Female; Glucocorticoids; | 2002 |
Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe.
Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Female; Glucocorticoids; Hormone Replacement Therapy | 2002 |
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.
Topics: Alendronate; Animals; Apoptosis; Bone Density; Bone Resorption; Cell Survival; Dexamethasone; Glucoc | 2002 |
Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Anti-Inflammatory Agents; Body Mass Index; Bone | 2002 |
Coincidence of asymptomatic avascular necrosis and fracture of the femoral neck: a rare combination of glucocorticoid induced side effects.
Topics: Azathioprine; Bone Density; Female; Femoral Neck Fractures; Femur Head Necrosis; Humans; Immunosuppr | 2002 |
Metabolic effects of corticosteroid therapy in post-menopausal women.
Topics: Androstenedione; Bone and Bones; Calcium; Creatinine; Dehydroepiandrosterone; Estradiol; Estrone; Fe | 1979 |
Possible prevention and treatment of steroid-induced osteoporosis.
Topics: Adult; Aged; Bendroflumethiazide; Calcium; Child; Dihydrotachysterol; Ergocalciferols; Female; Human | 1978 |
Distinction between the common symptoms of the phosphate-depletion syndrome and glucocorticoid-induced disease.
Topics: Antacids; Asthma; Calcium Gluconate; Diagnosis, Differential; Ergocalciferols; Humans; Male; Methylp | 1978 |
[Complication following long-term use of corticosteroid preparations].
Topics: Female; Humans; Middle Aged; Osteoporosis; Prednisolone; Prednisone | 1977 |
[Treatment of steroid-induced osteoporosis with thyrocalcitonin in chronic dermatoses].
Topics: Calcitonin; Chronic Disease; Dermatomycoses; Dexamethasone; Humans; Middle Aged; Osteoporosis; Pemph | 1978 |
Studies on osteoporosis I. Experimental models. Effect of age, sex, genetic background, diet, steroid and heparin treatment on calcium metabolism of mice.
Topics: Aging; Animals; Calcium; Calcium Radioisotopes; Diet; Disease Models, Animal; Female; Heparin; Male; | 1978 |
On the attempt to establish a model on steroid-induced osteoporosis in bones of rats.
Topics: Animals; Bone and Bones; Calcium; Calcium, Dietary; Cortisone; Disease Models, Animal; Male; Osteopo | 1975 |
On the effect of prednisolone on hamster bone.
Topics: Animals; Bone and Bones; Cricetinae; Elasticity; Femur; Fractures, Spontaneous; Osteoporosis; Predni | 1975 |
Corticosteroid induced osteoporosis in severe menstrual asthma. Steroid sparing drugs may be useful.
Topics: Adult; Asthma; Female; Humans; Menstruation Disturbances; Methotrexate; Osteoporosis; Prednisolone | 1992 |
Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma.
Topics: Biomarkers, Tumor; Bone Neoplasms; Calcium; Collagen; Female; Follow-Up Studies; Humans; Immunoglobu | 1992 |
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
Topics: Absorptiometry, Photon; Asthma; Bone Density; Female; Humans; Osteoporosis; Osteoporosis, Postmenopa | 1992 |
Effect of swimming on prednisolone-induced osteoporosis in elderly rats.
Topics: Aging; Animals; Body Water; Body Weight; Bone Density; Female; Ions; Magnetic Resonance Spectroscopy | 1992 |
Effect of glucocorticoids on bone Gla protein values--BGP as a good marker of osteoporosis.
Topics: Adolescent; Age Factors; Biomarkers; Bone and Bones; Child; Child, Preschool; Depression, Chemical; | 1991 |
Steroid-resistant bullous pemphigoid treated with cyclosporin A.
Topics: Aged; Cyclosporins; Drug Resistance; Female; Humans; Osteoporosis; Pemphigoid, Bullous; Prednisolone | 1991 |
[Osteoporosis in rheumatoid arthritis and related disorders].
Topics: Arthritis, Rheumatoid; Bone and Bones; Bone Resorption; Calcium; Cytokines; Estrogens; Female; Human | 1990 |
[Countermeasure for adverse effects of therapeutic agents for systemic lupus erythematosus].
Topics: Diabetes Mellitus; Humans; Immunosuppressive Agents; Infections; Lupus Erythematosus, Systemic; Oste | 1990 |
Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone and Bones; Bone Density; Calcitonin; Calcium; Fem | 1990 |
[Inhibition of prednisolone osteopathy by diphosphonate (EHDP) in an animal experiment].
Topics: Animals; Bone and Bones; Cricetinae; Etidronic Acid; Male; Mesocricetus; Osteoporosis; Prednisolone | 1989 |
[Complications of long-term corticotherapy: how to prevent?].
Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Growth; Humans; Osteoporosis; Prednisolone; Predniso | 1989 |
A 47-year-old woman presenting with a 20-year history of SLE.
Topics: Estrogens; Female; Humans; Lupus Erythematosus, Systemic; Menopause; Middle Aged; Osteoporosis; Pred | 1989 |
Biomarks in secondary osteoporosis.
Topics: Arthritis, Rheumatoid; Biomarkers; Calcium; Female; Gonadal Steroid Hormones; Humans; Middle Aged; M | 1989 |
Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study.
Topics: Arthritis, Rheumatoid; Bone and Bones; Female; Humans; Longitudinal Studies; Middle Aged; Osteoporos | 1989 |
Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Calcium-Binding Proteins; Co | 1989 |
[Spontaneous fracture and osteoporosis following renal transplantation].
Topics: Adolescent; Adult; Bone and Bones; Child; Child, Preschool; Female; Fractures, Spontaneous; Humans; | 1989 |
[Crohn disease: initial experiences with cyclosporin A in an adolescent girl].
Topics: Adolescent; Azathioprine; Crohn Disease; Cyclosporins; Female; Humans; Lymphoma; Osteoporosis; Predn | 1985 |
Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone and Bones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Femal | 1988 |
Effects of NaCl on calcium balance, parathyroid function and hydroxyproline excretion in prednisolone-treated rats consuming low calcium diet.
Topics: Absorption; Animals; Bone Resorption; Calcium; Cyclic AMP; Diet; Feces; Glucocorticoids; Hydroxyprol | 1986 |
Calcium metabolism and osteoporosis in corticosteroid-treated postmenopausal women.
Topics: Aged; Aged, 80 and over; Calcium; Creatinine; Female; Humans; Hydroxyproline; Menopause; Middle Aged | 1986 |
Determinants of axial bone loss in rheumatoid arthritis.
Topics: Aged; Arthritis, Rheumatoid; Female; Femur Neck; Humans; Lumbar Vertebrae; Male; Middle Aged; Osteop | 1987 |
Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.
Topics: Adult; Arthritis, Rheumatoid; Bone and Bones; Female; Humans; Menopause; Middle Aged; Osteoporosis; | 1986 |
[Diagnosis of steroid-induced lesions of bone tissue by gamma-photon absorptiometry].
Topics: Absorptiometry, Photon; Asthma; Female; Humans; Male; Osteoporosis; Prednisolone | 1986 |
[Osteoporosis in corticoid therapy of patients with chronic obstructive respiratory tract diseases].
Topics: Adrenal Cortex Hormones; Adult; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Lu | 1985 |
Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Bone and Bones; Calcitonin; Calcium; Flavonoids; Isoflavones; Male; Minerals; Osteoporosis; | 1986 |
Bone mass in corticosteroid treated patients with rheumatoid arthritis, asthma and polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Asthma; Female; Humans; Male; Osteoporosis; Polymyal | 1985 |
[Osteoporosis after long-term administration of corticoids].
Topics: Adult; Asthma; Humans; Male; Osteoporosis; Prednisolone; Time Factors | 1985 |
[Various problems in the diagnosis and treatment of plasmacytoma in the geriatric practice].
Topics: Aged; Antineoplastic Agents; Antitubercular Agents; Blood Protein Disorders; Blood Sedimentation; Bo | 1971 |
The glycosaminoglycans of compact bone tissue in experimental osteoporosis. Induced by combined oophorectomy and prednisolone treatment or prolonged calcium restriction in one year old rats.
Topics: Animals; Bone and Bones; Calcium; Castration; Deficiency Diseases; Female; Glycosaminoglycans; Hexos | 1968 |
The development of osteoporosis. Experimental studies in the adult rat.
Topics: Analysis of Variance; Animals; Body Weight; Bone and Bones; Bone Resorption; Calcium; Calcium Isotop | 1969 |
[What is guaranteed in the therapy of chronic hepatitis?].
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Diabetes Mellitus; Gastrointe | 1973 |
A planned approach to the surgical patient with iatrogenic adenocortical insufficiency.
Topics: Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Anesthetics; Blood Pressure; | 1968 |
The effect of Prednisolone upon the metabolism and action of 25-hydroxy-and 1,25-dihydroxyvitamin D3.
Topics: Animals; Biological Transport, Active; Calcium; Dihydroxycholecalciferols; Dose-Response Relationshi | 1974 |
Corticosteroid osteoporosis.
Topics: Adult; Aged; Aging; Arthritis, Rheumatoid; Asthma; Autoanalysis; Bone and Bones; Calcium; Calcium Ra | 1973 |
Extramedullary plasmocytoma.
Topics: Adult; Aged; Fractures, Bone; Hip; Humans; Lymph Nodes; Male; Maxillary Sinus; Melphalan; Middle Age | 1973 |
[Hazards of local corticoid therapy].
Topics: Administration, Topical; Adult; Aged; Ankylosis; Anti-Inflammatory Agents; Bursitis; Cellulitis; Dex | 1973 |
[Nature of complications in patients with pemphigus in long-term treatment with corticosteroid hormones].
Topics: Adult; Aged; Cushing Syndrome; Female; Humans; Hyperglycemia; Male; Middle Aged; Osteoporosis; Pemph | 1974 |
Osteoporosis and parathyroid glands. II. The parathyroids during combined oophorectomy and prolonged prednisolone administration in adult rats.
Topics: Animals; Body Weight; Calcium; Cell Nucleus; Female; Osteoporosis; Ovary; Parathyroid Glands; Parath | 1972 |
Clinical observations on the use of adrenal steroids. Comments on side effects and approaches to avoiding them.
Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Child; Glucocorticoids; Growth Disorders; Half-Life | 1972 |
[Bone metabolism and rheumatoid arthritis].
Topics: Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Arthritis, Rheumatoid; Bone and Bones; Calc | 1972 |
[Pathology of osteopathy following heparin therapy].
Topics: Blood Pressure Determination; Bone and Bones; Bone Diseases; Bone Regeneration; Calcification, Physi | 1969 |
[Cortisone-induced damages in a large group of traumatologic surgical patients].
Topics: Administration, Topical; Anti-Inflammatory Agents; Cortisone; Female; Glucocorticoids; Humans; Hydro | 1969 |
[Collagen metabolism and corticosteroids].
Topics: Age Factors; Animals; Bone and Bones; Collagen; Collagen Diseases; Hydroxyproline; Methylprednisolon | 1967 |
[Serum alkaline phosphatase in rheumatic diseases and its influencing by corticosteroids].
Topics: Adult; Aged; Alkaline Phosphatase; Arthritis, Rheumatoid; Female; Humans; Injections, Intramuscular; | 1968 |
The effect of combined oophorectomy and prednisolone administration on the skeletal tissue and calcium retention in one year old rats.
Topics: Animals; Bone and Bones; Calcium; Calcium Isotopes; Castration; Female; Osteoporosis; Ovary; Prednis | 1968 |
[Side-effects of glucocorticoids in liver therapy].
Topics: Acute Disease; Chronic Disease; Diabetes Mellitus; Fractures, Spontaneous; Glucocorticoids; Hepatiti | 1969 |